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Quantitative DWI as an early imaging biomarker of the response to chemoradiation in 
esophageal cancer 
By: Benjamin Charles Musall, B.S. 
Chair of Advisory Committee: Steven H. Lin, M.D. Ph.D. 
 
 For patients diagnosed with stages IIa-IIb esophageal cancer, the current standard of 
care treatment is tri-modality therapy (TMT), where neoadjuvant chemoradiation (nCRT) is 
followed by surgical resection. Histopathology of resected tumors reveals that pathological 
complete response (pCR) is achieved in 20-30% of patients through nCRT alone. Because of 
the high mortality and morbidity associated with esophagectomy, it may be advantageous for 
patients exhibiting pCR from nCRT alone to be placed under observation rather than 
completing their TMT. Therefore, a method for predicting response at an early time-point 
during nCRT is highly desirable. Conventional methods such as endoscopic ultrasound, re-
biopsy, and morphologic imaging are insufficient for this purpose. During nCRT, 
morphologic changes in tumors are often preceded by changes in the tumor biology. Diffusion 
Weighed Imaging (DWI) is an MRI modality which is sensitive to microscopic motion of 
water molecules in tissue. Quantitative DWI provides a measure of the cellular 
microenvironment which is impacted by cellularity, extra-cellular volume fraction, structure 
of the extracellular matrix, and cellular membranes. This work sought to investigate if 
changes in quantitative DWI may be used as an early imaging biomarker for the prediction of 
response to nCRT in esophageal cancer. 
DWI scans were performed on a small group of esophageal cancer patients (stages IIa 
to IIIb) before, at interim, and after completion of their nCRT. Quantitative diffusion 
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parameter maps were estimated for DWI scans using the following models of diffusion: 
mono-exponential, intra-voxel incoherent motion (IVIM), and kurtosis. Summary measures of 
quantitative diffusion parameters were extracted from tumor voxels through volumetric 
contouring. These summary measures were retrospectively compared between 
histopathologically confirmed groupings of patients as pCR and non-pCR. The study found 
that the relative change in mean ADC could completely separate groupings of pCR and non-
pCR patients (AUC=1) at a cutoff of 27.7%. Measurement by volume contouring was shown 
to be highly reproducible between readers. This pilot study demonstrates the promise of using 
DWI for organ sparing approaches after nCRT in esophageal cancer.  
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1 Introduction and Background 
1.1  Statement of Problem 
1.1.1 General Problem 
For a majority of cancer, patients undergo clinical management based on their cancer 
staging. The staging of the patients typically relies on their clinical status, lab tests, imaging, 
and biopsy. The actual treatment regimen is strongly influenced by clinical staging, the site 
of the malignancy, and the health of the patient. During the treatment, the patient may be 
restaged depending on the response. Because different patients of the same staging may 
respond to a treatment differently and every treatment has its toxicity, it is often critical to 
characterize individual disease and improve treatment selection on an individual basis. 
Evaluating treatment response for individual patients is an essential part of the clinical 
management of patients. In particular, prediction of treatment response at an early time point 
during therapy would allow for alteration of a patients therapy regimen to minimize the 
toxicity and maximize the efficiency of the treatment of the patients.  
Cancer therapies, with the obvious exception of surgery, are usually implemented 
over a series of weeks. For radiation therapy, a long treatment time is often needed to allow 
normal tissues to recover between treatments. For chemotherapy, long treatment times are 
needed to achieve the desired malignant cell kill while maintaining toxic chemotherapy 
agents at levels acceptable to the patient health. At the end of the therapy regimen, the 
response to treatment is often assessed by imaging and the histopathology of surgical 
specimens. Whenever available, histopathological metrics are considered a “gold standard” 
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for assessing how well an individual responded to therapy. There are also non-invasive 
metrics available after surgery: continued observance of changes in tumor morphology 
through imaging and prognostic FDG-PET imaging post-therapy. Although these excellent 
prognostic tools are available post-therapy, morphologic measures through conventional 
imaging as well as re-biopsy are insufficient for interrogation of patient response early during 
therapy. Changes in the tumor microenvironment, which are not visible morphologically, 
occur early during therapy. Quantitative Diffusion Weighted Imaging (DWI) provides a 
measure of these changes through its sensitivity to diffusion behavior of water molecules in 
tissue. Because of this, it may hold value as an early predictor of response.  
1.1.2 Specific Problem 
For esophageal cancers of stages IIa – IIIb, the current standardized of care is for 
patients to treated with neoadjuvant chemoradiation (nCRT), followed by surgical resection 
(1). Histopathological metrics post-surgery reveal that 20-30% of patients exhibits pathologic 
complete response (pCR) from chemoradiation alone (2-4). Surgical methods for removing 
esophageal tumors are highly invasive, with high risk of mortality and morbidity in these 
patients (5).  
A method of predicting a patient’s response early during their therapy would allow 
for pCR patients to forego surgery and instead be placed under observation. Conventional 
imaging methods, re-biopsy, and some basic genetic mutation characterization methods have 
been found to be insufficient for the purpose of predicting patient response (6-10).  
There is an unmet clinical need for a method which can provide an early prediction of 
response to chemoradiation in esophageal cancer. Measured changes in intra-tumoral 
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diffusion behavior of water molecules during treatment with quantitative DWI may be able to 
fulfill this need. 
1.2 Esophageal Cancer 
1.2.1 Epidemiology 
Esophageal cancer is the sixth leading cause of cancer-related mortality worldwide 
and its incidence is increasing (11). Overall 5-year survival is under 25%. Esophageal 
malignancies are separated into two major histologic groupings based on their tissue type of 
origin. Adenocarcinoma (EAC), which originates in esophageal glands, is more common in 
North America and Western Europe. Squamous cell carcinoma (ESCC), which originates in 
the squamous cells of the epithelium in the esophagus, is more common across Asia, South 
America, and southern Africa. A primary risk factor for EAC is high body mass index (BMI) 
(12). Due to the endemic of obesity, incidence of EAC is rapidly increasing. Primary risk 
factors for ESCC include smoking, poor diet, alcohol consumption (12). Across all 
esophageal cancers, incidence is four times more likely in men than in women (12). 
Esophageal cancers can also be divided according to the anatomic location of the 
disease. The esophagus can be divided into three distinct parts. A diagram of this division 
can be seen in Figure 1-1. 
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Figure 1-1: Illustration depicting regions of the esophagus. 
For AEC’s, the proximal third and middle third locations account for only a quarter of 
the cancers in esophageal cancers, while the remaining cancers are located in the distal third 
and gastroesophageal (GE) junction (12). ESCC is more commonly found in the middle 
third. Tumor location is important for radiation treatment planning and surgical planning. 
1.2.2 Detection and Staging 
Esophageal cancer is typically asymptomatic until sufficient tumor growth has 
occurred. Because of this, it is usually detected in later stages. Clinical symptoms include 
dysphagia (difficulty swallowing) and chest pain. After symptoms are reported, patients are 
examined and sent for further tests. Imaging methods used for diagnosing esophageal cancer 
include chest x-ray, barium swallow fluoroscopy, contrast CT, and FDG-PET. Once it is 
confirmed that the patient has cancer, their cancer is then staged. 
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Staging of esophageal cancer may include information gained from diagnostic 
imaging methods (13). It will also include endoscopic ultrasound (EUS) and biopsy. First, 
lesion characteristics are used to define the cancer by the TNM system of the American Joint 
Committee on Cancer (AJCC). In this system, lesions are given an initial T-stage based on 
the degree of their invasion from their site of origin into layers of surrounding tissue. In the 
esophagus, T1 implies that the cancer has spread into the epithelium; T2 implies spread into 
the muscularis propria; T3 implies that the cancer is growing into the adventitia, and T4 
implies local spread to nearby organs. An illustration of these tissue layers is given in Figure 
1-2. 
 
Figure 1-2: Layers of the esophagus. 
 N in TNM represents the relative number of local lymph nodes involved. Further, a 
binary M-staging is given, where M0 represents no metastatic spread and M1 represents 
metastatic spread. After this, groupings of the cancer are made based on location, TNM 
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staging, and biopsy grading of cell appearance. Stage I patients have no nodal involvement, no 
invasion beyond the epithelium, no metastases, and are well differentiated. Stages II-II are 
stratified into several levels based on variations of T and N stages as well as tumor location 
and cell grading. Stage IV implies metastatic disease. 
1.2.3 Treatment Strategy 
A treatment course is based on a comprehensive consideration of the initial staging 
and the health of the patient. For stage I, surgery is implemented immediately, and is usually 
curative (14). For stage IV, palliative treatment is given. For stages IIa through IIIb, the 
optimum treatment for patients is trimodality therapy (TMT) (15).  
1.2.3.1 Neoadjuvant Chemoradiation Therapy 
During TMT, neoadjuvant chemoradiotherapy (nCRT) is used to shrink the tumor and 
followed by resection in patients who are healthy enough to be considered for surgery. For 
radiation, tumors are irradiated to a total dose of 50.4 Gy (1.8 Gy/frac) over a period of 
approximately five weeks (1). Chemotherapy will accompany radiation, consisting of a 
combination of cisplatin and either docetaxel or fluorouracil (1). After completion of nCRT, 
a patient will undergo surgery. Some patients may be unable to undergo surgery because of 
health problems. In this case, their treatment regimen, consisting of only nCRT, is referred to 
as bimodality therapy (BMT). 
1.2.3.2 Surgical Excision 
Surgical resection has shown benefits for locoregional control over definitive 
chemoradiation (16). Esophagectomy requires a combined approach towards tumors from 
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both thoracic and abdominal cavities (17). Historically, this was performed through an open 
thoracotomy, where an incision is made in the pleural space of the chest (18). More recently, 
minimally invasive esophagectomy (MIE) through video-assisted thoracoscopic surgery 
(VATS) has become available. MIE does not require a formal pleural incision, and may be 
advantageous over open esophagectomy (19). Both techniques requires general anesthesia 
and insertion of breathing tubes into the lung. During esophagectomy, a number of adjacent 
lymph nodes are also extracted and examined for cancer spread. 
Even in experienced centers, post-operative mortality and morbidity from 
esophagectomy are in the range of 7-8% (20). This is due to both the radical nature of the 
surgery as well as the weakened state of the cancer patients after the chemoradiation. 
1.2.4 Evaluation of Treatment Response 
1.2.4.1 Post-CRT Methods 
Before surgery, a follow-up (FU) FDG-PET scan is taken for the detection of residual 
disease, as well as to check for metastatic spread. Qualitative evaluation of FDG-PET scans 
after induction chemotherapy has been shown to be highly prognostic of clinical outcome for 
both BMT and TMT patients (21). 
After surgery, sections of resected tumor are sent to a pathology laboratory and 
examined for residual disease. To accomplish this, the resected tissue is formed into slides 
and stained with the Hematoxylin and Eosin (H&E) stain. Hematoxylin stains nucleic acids 
such as DNA and RNA with a deep blue-purple color, and Eosin is a non-specific stain 
which labels proteins with a light pink. This H&E staining method is considered a gold 
standard for the examination of cancer histopathology (22). In this presentation, trained 
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experts in histopathology can discern cellular structures within the resected tissue. For the 
purpose of evaluating residual disease status, histopathologists will search H&E stained 
slides for cancer cells and cancer structures which have survived treatment. Several methods 
of grouping patients by their post-treatment pathology, or restaging, have been presented in 
literature (23). An early grouping method was described for esophageal cancer by Mandard 
et al. and is based on a qualitative assessment of surviving cancer cells (24). Visual depiction 
of these groupings and their descriptions can be seen in Figure 1-3. 
 
Figure 1-3: Tumor Regression Grades by Mandard grouping depicted as illustrations. 
In the Mandard method, patients are placed in tumor regression groups based on 
subjective qualitative measures. At MDACC, an quantitative adaptation of the Mandard 
method known as the four-tiered grading system is used (25). In this method, a term called 
viable cell percentage is derived by comparing of the relative areas occupied by cancer cells 
and normal tissue. In the four-tiered system, TRG1 corresponds to 0% viable cancer cells or 
pathologic complete response (pCR). TRG2 corresponds to measures of tumor cells between 
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<1% to 10% viable cells. TRG3 corresponds to >10% to 50% viable cancer cells, and TRG4 
corresponds to >50% viable tumor cells. 
1.2.4.2 Early Prediction of Response 
Previously, several possible methods of predicting response of esophageal therapy 
during nCRT have been examined. Endoscopic US combined with biopsy has been shown as 
insufficient for predicting pCR (6, 7). A potential reason is that morphologic changes visible 
with US may not be present at an early time-point during therapy, and biopsy is always 
limited by its sampling errors. Likewise, CT and T2-weighted MR imaging are not able to 
predict response (26). Genetic characterization has shown minor successes (8-10) but does 
not yet have the sensitivity needed to predict pCR. Quantitative FDG-PET has also shown 
some success (7, 27), but is difficult to measure during therapy because of non-specific 
uptake caused by radiation induced inflammation. FDG-PET results may improve in future 
studies due to improved protocol design and improved methods for acquiring FDG-PET 
parameter summary measurements. 
Multi-parametric MRI is being investigated for predicting therapy response in cancers 
with increasing frequency and varying success (28). In a previous study, quantitative 
diffusion MRI has demonstrated excellent sensitivity to pCR (29). The protocols within this 
thesis were designed, in part, as a validation of this previous study by Van Rossum et al. 
Dynamic Contrast Enhanced (DCE) MRI has also been shown to have value for response 
prediction (30), but suffers from poor reproducibility. 
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1.3 Magnetic Resonance Imaging 
This purpose of this section is two-fold. The first is to demonstrate an understanding 
of MRI from a fundamental level. The second is to later extend these fundamental 
explanations to the more specific and advanced MRI methods used in the MRI research 
protocols of this thesis. 
1.3.1 Basic Principles of MRI 
1.3.1.1 Behavior of Protons in a Magnetic Field 
For atomic isotopes with an odd number of nucleons, the net angular momentum of 
the system is non-zero. In the case of protium (1H), the contribution of a single proton creates 
a net angular momentum or “spin” of +/- ½. When a proton is placed in an external magnetic 
field, this non-zero spin will align with the direction of the external magnetic field and 
precess about this direction. The frequency of precession is referred to as the Larmor 
frequency, and it is dependent on both the strength of the external magnetic field (B0) as well 
as the intrinsic gyromagnetic ratio of the proton (42.58 MHz/T). This relationship is 
described in the Larmor equation: 
Equation 1: 𝝎𝟎 = 𝜸𝑩𝟎 
where ω0 is the Larmor frequency, γ is the gyromagnetic ratio, and B0 is the external 
magnetic field strength. 
In a group of protons, not all of the protons will align with the magnetic field 
(parallel). A slightly smaller amount of them will align in the direction opposite the external 
magnetic field (anti-parallel). At 25̊ C, thermal energy is sufficient to induce changes 
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between these two quantum states in individual proton spins. Despite this, a sufficiently large 
group of protons will always have slightly more spins in the parallel state, creating a bulk 
magnetization. This magnetization is proportional to B0 and inversely proportional to 
temperature. This relationship is described through combination of a Maxwell’s Laws and a 
Boltzmann distribution in Equation 2: 
Equation 2: 𝑴𝟎 = 
𝝆𝟎𝜸
𝟐ℏ𝟐
𝟒𝒌𝑻
𝑩𝟎 
where M0 is the net magnetization per unit volume, ρ0 is the density of protons, γ is the 
gyromagnetic ratio, ћ is the Planck’s constant, k is the Boltzmann constant, T is temperature, 
and B0 is the external magnetic field. In MRI, B0 refers to the static magnetic field. This net 
magnetization is depicted in Figure 1-4. 
 
Figure 1-4: Diagram indicating excess alignment of spins with B0 to form the net 
magnetization M0. Conventional designation of Cartesian dimensions is also shown. 
The high density of water protons in vivo combined with high magnetic field 
strengths in clinical MRI scanners create a relatively large bulk magnetization in tissue. This 
bulk magnetization and its properties are used for imaging with MRI. 
12 
 
1.3.1.2 Bloch Equations 
The group behavior of spins or bulk magnetization can be derived from Maxwell’s 
laws, and were first described mathematically by Felix Bloch in 1946 (31). Behavior of bulk 
magnetization in the presence of external magnetic fields can be described through the Bloch 
equation: 
Equation 3: 
𝒅?⃑⃑⃑? (𝒕)
𝒅𝒕
= 𝜸?⃑⃑⃑? (𝒕) × ?⃑⃑? 𝒆𝒙𝒕 −
𝑴𝒕𝒓𝒂𝒏𝒔𝒗𝒆𝒓𝒔𝒆
𝑻𝟐
−
𝑴𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍− 𝑴𝟎,𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍
𝑻𝟏
 
where M(t) is the time-variant magnetization of the sample, γ is the gyromagnetic ratio, Bext 
is the vector of combined external magnetizations, Mtransverse is the magnetization of the 
sample transverse to B0, T2 is the spin-spin relaxation constant, Mparallel is the magnetization 
of the sample parallel to B0, and T1 is the spin-lattice relaxation constant. Spin-spin 
relaxation, or T2, refers to dephasing of spins in the transverse plan by exchange of angular 
momentum between spins through dipole-dipole interactions, variations in the local magnetic 
fields, and other interactions (32). As implied in the combined Bloch equation, T2 relaxation 
through gradual misalignment of individual spins results in an exponential decay of 
Mtransverse. T2 is also affected by B0 inhomogeneities, which result in a shorter apparent T2 
relaxation time referred to as T2*. Separately, T1 relaxation refers to the exponential recovery 
of Mparallel as magnetization returns from an excited state to its steady state alignment with B0. 
Both T2 and T1 relaxations create exponential decay of the transverse net magnetization. T2 
refers to the time when 63% of transverse magnetization has been lost to spin-spin relaxation 
and T1 refers to a time where 63% of the magnetization has realigned with B0. In tissue, these 
relation times are variable between tissue types. This variation in relaxation times between 
tissues is used as a source of contrast in anatomic imaging.  
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By selecting a time of measurement which maximizes the difference in transverse 
magnetization between tissues of differing T1 or T2, a weighted contrast can be optimized for 
the image. For individual tissues, T1 is always longer than T2. Thus, relatively short 
measurement times (echo time, TE) with little recovery between measurements (repetition 
time, TR) produce greater emphasis on T1 differences and are considered T1-weighted. 
Conversely, relatively long TE and long TR emphasize T2 differences and considered T2-
weighted. Short TE and long TR minimize effects of both T1 and T2 relaxations on 
measurement, and give way to a proton density weighting of measurements. 
1.3.1.3 Signal Generation 
To detect the bulk magnetization of protons in a magnetized sample, the 
magnetization must be re-oriented into the transverse plane. This may be accomplished 
through the application of an oscillating secondary magnetic field, B1. In MRI, this B1 field 
must oscillate with a frequency equal to Larmor frequency of protons within the B0 field. At 
the B0 strength of a clinical MRI scanner, an oscillating magnetic field of this frequency falls 
within the range of the electromagnetic spectrum corresponding to radio waves. Because of 
this, B1 fields are also referred to as a radiofrequency (RF) pulse. The force imparted from a 
B1 field transverse to B0 can be used to nutate the net magnetization of the sample into the 
transverse plane. The angle of this nutation or flip is dependent on the magnitude and 
duration of the RF pulse, as shown in Equation 4: 
Equation 4: ∝=  𝜸∫𝑩𝟏(𝒕)𝒅𝒕 
where α is the flip angle, γ is the gyromagnetic ratio, and B1 is the magnitude of the RF 
pulse. A pulse which tips magnetization from its steady state alignment with B0 into the 
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transverse plane is referred to as an excitation pulse. If the magnetization is left undisturbed 
after its excitation, an exponential decay of its transverse component called Free Induction 
Decay (FID) will occur by T2* relaxation.  
Through an interaction described by Faraday’s Law, the transverse magnetization 
induced emf or an electric current in orthogonally placed conducting loops. In MRI, these 
conducting loops are known as receiver coils. Although receiver coils are more sensitive to 
nearby changing magnetization in accordance with the inverse square law, they are unable to 
fully spatially localize spins. Thus, a technique for spatially encoding spins into received 
signal must be utilized. 
1.3.1.4 Location Encoding 
The addition of spatially variant magnetic fields is used to localize magnetization in 
MR imaging. In Cartesian imaging, localization must be accomplished in three dimensions. 
While the direction of these dimensions is arbitrary and may be altered to better portray 
certain anatomies, a majority of MRI acquisitions are taken as axial images. For localization 
in axial imaging, the three spatial dimensions may be separated into two types: the dimension 
which is parallel to the B0 field (the z-axis, by convention) and the two dimensions of the 
transverse plane (x-y plane, by convention).  
Localization along the z-axis is also known as slice selection. For visualization of 
axial images, variations in signal are displayed on the transverse plane or “slice”, while the z-
axis is implicit and unseen dimension corresponding to the thickness of the visualized 
anatomy. A technique for selection of a slice of certain location and thickness was first 
described by Peter Mansfield in the 1970’s (33). The desired thickness and location of a slice 
is selected during excitation with the addition of a gradient field Gz, which creates a linear 
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variation in the Larmor frequency along the z-axis. A slice of spins may be selectively 
excited using an RF pulse whose central frequency and bandwidth are limited to the Larmor 
frequency range present within spins of the desired slice. This relation is detailed in Equation 
5: 
Equation 5: 𝑩𝑾𝑹𝑭 =  𝜸𝑮𝒁∆𝒛 
where BWRF is the frequency bandwidth of the RF pulse, γ is the gyromagnetic ratio, Gz is 
the slice selection gradient, and Δz is the thickness of the sample intended for excitation. In 
this equation, it is implied that the central frequency of the RF pulse corresponds to the 
Larmor frequency of spins centered in the z-dimension of the slice. This process of slice 
selective excitation may by reapplied if multiple RF pulses are used sequentially. A visual 
illustration of slice selective excitation can be seen in Figure 1-5. 
 
Figure 1-5: Slice selection through application of magnetic field gradient in combination 
with a selective bandwidth (W) RF pulse. 
Although encoding in the transverse dimensions is also accomplished with spatially 
varying magnetic fields, their implementation is different. Unlike slice selection, the two 
transverse dimensions are encoded directly into the signal which is read-out by the receiver 
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coils. The two linear magnetic fields, Gx and Gy, do not isolate signal from a specific point 
within the imaging plane. Rather, these gradients produce spatial variations in the 
contribution of all excited spins. Transverse gradients are used to create spatial variation of 
magnetic field across the transverse dimension, which produces spatial variation in the 
Larmor frequency of spins. Over the duration of the gradient, the variable spin frequencies 
will result in spatially varying directionality of magnetization. This may also be referred to as 
an accumulation of phase. The amount of phase accumulated during the application of the 
gradient is dependent on the position of the spin as well as the magnitude and duration of the 
gradient. This is described mathematically by Equation 6: 
Equation 6: 𝜽 =  𝜸∫𝑮𝒙(𝒙, 𝒕)𝒙𝒅𝒕 
where θ is the accumulated phase, γ is the gyromagnetic ratio, Gx(x) is the strength of the 
gradient at location x, and x is the location of the spin.  
Because phase is periodic, its variation will occur cyclically along the direction of the 
gradient. This phenomenon is better known as spatial frequency, with units of inverse unit 
length. The spatial frequency in spins produced through application of a gradient field is 
described in Equation 7: 
Equation 7: 𝒌 =  𝜸 ∫𝑮(𝒕)𝒅𝒕 
where k is the spatial frequency, γ is the gyromagnetic ratio, and G is the magnitude of the 
gradient. During an acquisition, information will be sampled using spatial frequencies of 
varying magnitude and direction across the transverse plane. The signal collected from this 
acquisition can be plotted in k-space, which is the conjugate of image space. A comparison 
of these spaces can be seen in Figure 1-6. 
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Figure 1-6: Image space and k-Space of a T2-weighted image of a human thorax. 
By using the inverse Fourier transform to change the dimensionality of the data, the 
k-space acquisition may be converted into image space. The Fourier relationship between k-
space and image space is described by Equation 8: 
Equation 8: 𝑺(𝒌𝒙, 𝒌𝒚) =  ∬𝝆(𝒓)𝒆
−𝒊𝟐𝝅(𝒌𝒙𝒙+𝒌𝒚𝒚) 
where S(kx,ky) is the distribution of signal in k-space, ρ(r) is the spatial distribution of spins 
or proton density, kx/ky are the Cartesian coordinates of different spatial frequencies in k-
space, and x/y is the location of spins in Cartesian image space. The central area of k-space 
(near the origin) contains information on low spatial frequencies of the system. It serves as 
the primary source of image contrast and has a relatively high signal. The outer section of k-
space contains information on higher spatial frequencies. It has relatively small signal, and its 
extent determines the spatial resolution of an image. 
In conventional MRI, filling k-space can be more efficiently accomplished by 
continuous readout along one dimension (referred to as frequency encoding) and stepped 
along another (phase encoding). By convention, the x-direction is typically considered as the 
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frequency encoding direction, while the y-dimension is typically considered the phase 
encoding dimension. A gradient pulse diagram and k-space trajectory of this conventional 
acquisition method can be seen in Figure 1-7. 
 
Figure 1-7: Gradient encoding of 2D Fourier data as a both gradient waveform and as a 
k-space trajectory. Phase encoding is shown in orange, and frequency encoding is shown 
in green. 
1.3.1.5 Basic Pulse Sequences 
In MRI, two basic pulse sequences underlie most of clinical imaging: spin-echo (SE) 
and gradient-echo (GE). The GE pulse sequence uses the FID signal for spatial encoding. In 
contrast, the SE pulse sequence uses the spin echo signal from the application of an 
excitation/refocusing RF pulse pair for spatial encoding. 
In spin-echo sequences, a second RF pulse (B1) is applied to the spins with a flip 
angle of 180̊. This 180̊ pulse is typically applied orthogonally to both the B0 field and the 
excitation pulse. The 180̊ pulse flips the spins in the transverse plane to their conjugate 
direction so that dephasing of different spins due to B0 inhomogeneities is reversed. This 
rewinds the phase evolution of the spins to form coherent signal in the form of an echo. 
Because the dephasing effects of B0 inhomogeneities are reversed, the observed T2 contrast at 
the echo is attributable to T2 alone rather than T2*. It is advantageous to select a flip angle of 
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90̊ for SE because it maximizes the signal. A pulse sequence diagram for a typical SE 
sequence with conventional location encoding can be seen in Figure 1-8. 
 
Figure 1-8: A typical SE sequence. The pulse sequence, gradient waveform, and readout 
signal are shown. 
For GE, a true echo is not formed. Instead, a bipolar gradient is used to form a fast 
dephasing and rephasing of spins, during which transverse magnetization behaves similarly 
to an echo. The first lobe of the bipolar gradient dephases the spins by a known amount and 
the second opposing lobe of the gradient rephases the spins to create the “echo”. Because the 
effects of B0 inhomogeneities are not reversed, the signal amplitude GE sequence decays 
with T2*. GE imaging does not require a 90̊ flip angle for the initial excitation pulse, 
allowing for selection of a flip angle which is optimized by application and anatomy of 
interest. A pulse sequence diagram for a typical GE sequence with conventional location 
encoding can be seen in Figure 1-9. 
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Figure 1-9: A typical GE sequence. The pulse sequence, gradient waveform, and readout 
signal are shown. 
Pulse sequence selection is application dependent. For T2-weighted imaging, SE-
based sequences are favorable because they can remove T2* effects from contrast. GE 
imaging is useful for fast T1-weighted imaging because of short TR and low flip angle. These 
are generalizations for the basic forms of these pulse sequences. Advanced methods of 
applying SE and GE have been developed which defy the limits of their general forms and 
extend their usefulness. For diffusion imaging, both may be used, but SE is favored for 
reasons described in the following section. 
1.4 Diffusion Weighted Imaging 
1.4.1 Diffusion Behavior 
1.4.1.1 Idealized Diffusion by Random Brownian Motion 
Diffusion refers to the random Brownian motion of particles driven by entropy and 
thermal energy. It was first described mathematically by Adolf Fick (34), who presented 
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diffusion as random movement of a species along a concentration gradient. This formulation 
is shown in Equation 9: 
Equation 9: 
𝒅𝒄𝒊
𝒅𝒕
= 𝑫𝒊𝛁
𝟐𝒄𝒊 
where ci is the concentration of a molecular species within a medium and D is the diffusion 
coefficient with units of length squared over time. With the assumption of Gaussian diffusion 
behavior, the diffusion coefficient can be more simply explained with Albert Einstein’s 
derivation in Equation 10: 
Equation 10: 𝑫 = 
<𝒙𝟐>
𝟐𝒕
 
where D is the diffusion coefficient from Fick’s Law, <x2> is the 1D mean-squared 
displacement of the particle from its original position, and t is the length of time over which 
the particle diffused. For a particle of water in a homogenous water medium at a typical 
human body temperature (37̊ C), the diffusion coefficient would be approximately 1 x 10-3 
mm2/s (35). Solution of Equation 10 shows that if a water molecule was allowed to diffuse in 
these conditions for 100 ms, it would travel an average of 25 μm from its original position. It 
can be seen in this derivation, that for a particle with a given diffusion coefficient, diffusion 
over a certain time scale corresponds with a certain “length-scale”. 
Einstein further described the diffusion coefficient in his Ph.D. thesis through the 
Stokes-Einstein equation for 3D diffusion of spherical particles in a medium. This is shown 
in Equation 11: 
Equation 11: 𝑫 = 
𝑹𝑻
𝑵𝒂
𝟏
𝟔𝝅𝜼𝒂𝒓
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where D is the diffusion coefficient, R is the gas constant, T is the absolute temperature, Na is 
Avogadro’s number, ηa is the viscosity of the solvent, and r is the radius of the particle. This 
equation implies that the diffusion coefficient of a spherical particle is dependent on three 
variables: temperature, particle size, and the viscosity of the solvent.  
1.4.1.2 Diffusion in Tissue 
In tissue, temperature is constrained to its range within the human body, which is not 
highly variable in term of absolute temperature. Particle size and shape are constricted to that 
of water. Although MRI is also sensitive to magnetization of fat, efforts are taken to remove 
fat contribution to signal from the contribution of water in DWI. This leaves the viscosity as 
the major impactor of the diffusion coefficients in MRI measurements of diffusion. However, 
the Stokes-Einstein equation is limited to systems of quiescent and homogenous fluid. 
Biological tissue satisfies neither of these assumptions.  
The assumption of quiescence fails due to perfusion and bulk motion of water 
molecules in tissue. These perfusion effects occur on larger length-scales than pure diffusion, 
but are important in MRI measurement of diffusion. The assumption of homogeneity fails 
because of the varied makeup of biological tissue. Water molecules exists in a biological 
solvent of heterogeneous composition. While moving, these water molecules also may 
encounter barriers such as cellular membranes, organelle membranes, large macromolecules, 
and components of the extra-cellular matrix (ECM). Because of this, the diffusion coefficient 
of water in tissue is a product of complex set of interactions between water molecules and 
various organic structures. Previously, MRI measurements of diffusion in tissue has been 
shown to relate to cellularity (36), ECM composition (37), extracellular volume fraction 
(ECVF) (38), and membrane permeability (39). Historically, measurement of diffusion 
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coefficient by MRI rose in popularity because the diffusion coefficient is able to detect stroke 
and classify it by type after the stroke occurs (40). 
1.4.1.3 Diffusion in Cancer 
In cancerous tissues, rampant uncontrolled cell growth leads to high cellularity within 
tumors. This, among other possible factors, leads to lower mobility of water in malignant 
tissue and a lower diffusion coefficient in malignant tissue. An illustration showing restricted 
diffusion can be seen in Figure 1-10. 
 
Figure 1-10: Illustrations depicting movement of water molecules within tissues of 
varying cellularity. The blue line represents the random movement of a water molecule 
while the black circles represent cells. Republished with permission (License ID = 
4167471220873 from ww.copyright.com) from original article: O'Flynn, E. A. M., and N. 
M. deSouza. 2011. Functional magnetic resonance: biomarkers of response in breast 
cancer. Breast Cancer Research : BCR 13: 204. 
Because of this phenomena, images with diffusion-based contrast as well as estimated 
maps of the diffusion coefficient are able to delineate cancer and normal tissue. This has been 
used for detection (41-43), T-staging (44), and N-staging (45) for a variety of cancers. 
This project is focused on changes in diffusion throughout therapy. In tumors treated 
with conventional therapies such as chemotherapy and radiation (and some other therapies), 
water mobility increases after treatment (26). It has been shown in several anatomic sites that 
changes in diffusion at an early time-point during treatment are different between patients 
who exhibit good response to treatment and patients who exhibit poor response to treatment 
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(29, 46-48). Patients exhibiting good response to therapy show a larger relative increase in 
water mobility in comparison to patients with partial or poor response to therapy. 
1.4.2 Diffusion Sensitization and Contrast in MRI 
The effects of diffusion are ever present in MRI images. This is because T2 relaxation 
is partially mediated by diffusion. Diffusion weighted imaging (DWI) describes MRI pulse 
sequences and acquisition methods which attempt to isolate diffusion as a contrast 
mechanism. The Bloch equation (Equation 3) has previously been extended by H.C. Torrey 
using Fick’s Law (Equation 9) to include the effects of diffusion (49). The Bloch-Torrey 
formulation is shown below in Equation 12: 
Equation 12: 
𝒅?⃑⃑⃑? (𝒕)
𝒅𝒕
= 𝜸?⃑⃑⃑? (𝒕) × ?⃑⃑? 𝒆𝒙𝒕 −
𝑴𝒕𝒓𝒂𝒏𝒔𝒗𝒆𝒓𝒔𝒆
𝑻𝟐
−
𝑴𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍− 𝑴𝟎,𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍
𝑻𝟏
+ 𝑫𝛁𝟐?⃑⃑⃑? (t) 
where M(t) is the time-variant magnetization of the sample, γ is the gyromagnetic ratio, Bext 
is the vector of combined external magnetizations, Mtransverse is the magnetization of the 
sample transverse to B0, T2 is the spin-spin relaxation constant, Mparallel is the magnetization 
of the sample parallel to B0, T1 is the spin-lattice relaxation constant, and D is the diffusion 
coefficient. If relaxation terms are neglected, only transverse magnetization is considered, 
and only gradient fields are accounted for, Equation 13 will result: 
Equation 13: 
𝒅?⃑⃑⃑? (?⃑? ,𝒕)
𝒅𝒕
= −𝒊𝜸(?⃑? ∙ 𝑮(𝒙)⃑⃑ ⃑⃑ ⃑⃑ ⃑⃑  ⃑)?⃑⃑⃑? (?⃑? , 𝒕) +  𝑫𝛁𝟐?⃑⃑⃑? (?⃑? , 𝒕) 
where M(r,t) is the time and space dependent magnetization of the sample, γ is the 
gyromagnetic ratio, the vector r is the spin location, G(x) is the external gradient as a 
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function of location, and D is the diffusion coefficient. For the case in which D=0, integration 
of Equation 13 will result in Equation 6.  
The method of diffusion sensitization which is used in MRI was initially 
demonstrated by E.O. Stejskal and J.E. Tanner in an NMR experiment (50). Their method 
takes the form of a pair of pulsed gradients (known as Stejskal –Tanner gradients) the first of 
which encodes spin location with dephasing throughout the sample and the second of which 
provides the opposite location-based rephasing, forcing realignment of non-moving spins. 
Spins that experience these gradients at different positions will not experience complete 
rephasing. This causes dephasing of the spins and a loss of signal in areas where spins are 
mobile. The pulsed gradient SE (PGSE) implementation of Stejskal-Tanner gradients as well 
as an illustration of its effects on moving and non-moving spins can be seen in Figure 1-11. 
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Figure 1-11: Pulse sequence and simplified gradient waveform for a PGSE sequence. The 
gradient duration is labeled with δ, and the time elapsed between gradient is labeled with 
Δ. At the bottom, an illustration is shown comparing dephasing and rephasing effects on 
the magnetization of moving (red) and non-moving (blue) spins. 
The effects of these diffusion sensitization gradients on MR signal can be desscribed 
through further derivation of Equation 13. Stejskal and Tanner used bounds imposed by their 
pulsed gradient experiment to derive a mono-exponential model of diffusion from the Bloch-
Torrey equation, which is shown in Equation 14. 
Equation 14: 
𝑺
𝑺𝟎
= 𝒆−𝑫∗𝜸
𝟐𝑮𝟐𝜹𝟐(∆−
𝜹
𝟑
)
 
where S is the signal level of the diffusion images, γ is the gyromagnetic ratio, G is the 
magnitude of a single gradient, δ is the duration of a single gradient pulse, and Δ is the time 
lapse between the pulsed gradients. This derivation shows that the degree of signal loss is 
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dependent upon several variables. The variable of interest is the diffusion coefficient of the 
tissue. The remainder of the variables affecting the degree of signal loss include the strength 
of the location encoding gradients (magnitude), the duration of the location encoding pulse, 
and the time between the pulses (during which spins are allowed to move). These variables 
are grouped into a single parameter known as the b-value (alternatively as the b-factor). The 
formulation for the b-value is shown in Equation 15: 
Equation 15: 𝒃 =  𝜸𝟐𝑮𝟐𝜹𝟐(∆ −
𝜹
𝟑
) 
where γ is the gyromagnetic ratio, G is the magnitude of a single gradient, δ is the duration of 
a single gradient pulse, and Δ is the time lapse between the pulsed gradients. Diffusion 
images acquired with a certain b-value are referred to by bVALUE (Ex: Images acquired at b 
= 200 s/mm2 are referred to as b200 images). The maximum b-value an MRI scanner can 
produce with constant Δ is limited by its gradient hardware. It should be noted that identical 
b-values might be achieved with different combinations of gradient pulse areas, gradient 
pulse durations, and diffusion times. For the purposes of the experiments in this thesis, b-
value is assumed to be the only technique factor impacting signal, although this is not 
necessarily true (51).  
Other sources of contrast are minimized in diffusion scans by maintaining TE and TR 
across diffusion images with different b-values. This helps to minimize deviation from the 
assumptions made in Equation 13. 
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1.4.3 Models of Diffusion in MRI 
1.4.3.1 Mono-Exponential Model 
The simplest model of diffusion, the mono-exponential model (Equation 14), is the 
product of direct derivation of the Bloch-Torrey equation. Even if anatomic motion is 
ignored, the diffusion coefficient from this equation is the result of a complex combination of 
spin motion phenomena which are interrogated with Stejskal-Tanner gradients. In 
acknowledgement of these complex phenomena underlying this measurement, the mono-
exponential diffusion coefficient is referred to as the apparent diffusion coefficient (ADC).  
Violations of the assumptions used to derive Equation 14 may be included in more 
complex diffusion models. This is done both for the purpose of better estimating the true 
diffusion coefficient as well as identifying other factors affecting diffusion contrast separate 
from initial assumptions. In order to separate these other factors from the diffusion 
coefficient, b-values must be chosen which characterize spin motion on two separate ranges 
length-scales. These two ranges of b-values must be chosen so that in one range, the 
diffusion coefficient is the dominant contrast mechanism and in the other range, signal levels 
are impacted by both the diffusion coefficient and the other factor. Mathematical 
comparisons of signals over these two range of b-values will then allow for isolation of the 
diffusion model parameters. At low b-values, perfusion of microvasculature causes a 
deviation from mono-exponential diffusion behavior shown as signal loss beyond that 
expected of diffusion alone. At high b-values, deviations from the assumption of Gaussian 
diffusion, or kurtosis, cause an opposite deviation in signal where measured signal is higher 
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than what is expected from diffusion alone. A plot detailing these effects can be found in 
Figure 1-12. 
 
Figure 1-12: Graphical depiction of deviations in signal levels due to perfusion effects 
(red) at low b-values and from kurtosis effects (green) at high b-values. 
1.4.3.2 Intra-voxel Incoherent Motion Model 
In the case of lower b-values (tissue dependent, typically in the approximate range of 
0 to 300 s/mm2), larger length-scales of motion are interrogated and signal loss is due to a 
combination of diffusion and perfusion effects. Perfusion stems from microcirculation in 
capillaries within a given voxel, and is the dominant mechanism of signal loss in this range 
of b-values. Signal loss from perfusion will reach a limit, and at higher ranges of b-values 
will not further impact signal loss. A modeling method for perfusion effects, originally 
described by Denis Le Bihan, is the intra-voxel incoherent motion (IVIM) model (52). In this 
model, it is assumed that the orientation of capillaries within a given voxel is random, and 
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movement of fluids through these voxels mimics the random motion of diffusion on a larger 
length-scale. A visual depiction of this random capillary orientation can be seen in Figure 
1-13. 
 
Figure 1-13: Random orientation of capillaries within a hypothetical voxel of tissue. 
Republished with permission (License ID = 4167550994385 from ww.copyright.com) 
from original article: Malyar, N. M., M. Gossl, P. E. Beighley, and E. L. Ritman. 2004. 
Relationship between arterial diameter and perfused tissue volume in myocardial 
microcirculation: a micro-CT-based analysis. American journal of physiology. Heart and 
circulatory physiology 286: H2386-2392. 
On this basis, contribution of perfusion motion to signal loss may be simply modeled 
as a second exponential, whose contribution to signal loss is limited to a maximum effect 
reached at low b-values. This IVIM model is stated in Equation 16. 
Equation 16: 
𝑺
𝑺𝟎
= (𝟏 − 𝒇)𝐞−𝐛∗𝐃 + 𝒇𝒆−𝒃∗𝑫
∗
 
where f is the perfusion fraction, D is the true diffusion coefficient, and D* is the pseudo-
diffusion coefficient representing the b-value dependent contribution of perfusion to signal 
loss. In general, this D* coefficient is an order of magnitude larger than D coefficient (52). 
31 
 
This model has been used for application in cancer with varying success (43, 53, 54). 
When selecting b-values for this exam, it is important to select multiple low b-values to fully 
characterize the perfusion effects on signal loss (55). 
1.4.3.3 Diffusion Kurtosis Model 
When diffusion is probed on a small length-scale, barriers such as cell membranes 
pose a greater effect on the diffusion probability distribution (Equation 10) of water 
molecules. This is because these barriers block a significant portion of nearby space (relative 
to length-scale). The presence of barriers of any shape will alter the diffusion probability 
function so that shorter diffusion lengths are more likely. This is a violation of the 
assumption of Gaussian diffusion behavior, and results in a compression of the ideal 
Gaussian distribution of the diffusion probability density function. This means reducing the 
probability of values in the tails and increasing the probability of values close to the mean, as 
shown in Figure 1-14. 
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Figure 1-14: Depiction of probability function distributions with differing kurtosis. The 
kurtosis observed in diffusion is positive, which is depicted as a change in the probability 
density function from the red plot to the green plot. 
This change in the distribution of the diffusion probability function can be described 
as a Gaussian function altered with a kurtosis parameter (56). The kurtosis of a distribution is 
the fourth moment mathematically, and it can be calculated for diffusion using Equation 17: 
Equation 17: 𝒌(𝒙) =  
𝝁𝟒
𝝈𝟒
= 
<(𝒏∙𝒔)𝟒>
<(𝒏∙𝒔)𝟐>𝟐
 
where k is the kurtosis parameter, μ is the average diffusion distance, σ is the standard 
deviation of the probability function, n is the unit vector and s is the diffusion distance 
vector. If this kurtosis term is incorporated in the derivation of Equation 14, Equation 18 will 
result (56): 
Equation 18: 
𝑺
𝑺𝟎
=  𝒆−𝒃∗𝑨𝑫𝑪+
𝟏
𝟔
𝒃𝟐𝑨𝑫𝑪𝟐𝒌 
 
Examination of this equation shows an intuitive mathematical relationship between 
signal levels and the kurtosis effect. As length-scale is decreased (b-value increases), the 
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effects of kurtosis (barriers blocking diffusion) is increased (second order relationship to b-
values). This reduces signal loss from diffusion, as molecules are less likely to diffuse as far. 
This can be seen in Figure 1-12, where kurtosis effect is evident at higher b-values (1000 
s/mm2 and upwards). Measurement of the kurtosis parameter is shown to be useful for 
various applications in cancer at several anatomic sites (57-59). 
1.4.4 Advanced MRI Techniques for DWI 
Many advanced MRI techniques have been developed and implemented since the 
birth of MRI. This section aims to explain a few important techniques which have been used 
in this project and are essential for clinical implementation of DWI. Several of these 
techniques provide acquisition acceleration. This acceleration serves to improve 
reproducibility and image quality of diffusion images and lower scan times. Another 
important technological development is the increase of gradient strength. As recently as 25 
years ago, maximum b-values achievable on a clinical scanner were on the order of 200 
s/mm2 (51). The development of these techniques and gradient technology has been essential 
for clinical implementation of fast and reproducible diffusion imaging. 
1.4.4.1 Echo Planar Imaging 
Echo Planar Imaging (EPI) was first described by Peter Mansfield in 1977 (60). EPI 
is an acquisition in which all or most of k-space is collected in a single TR. Single-shot EPI 
(ssEPI) describes EPI in which the entirety of k-space is collected in one TR, whereas multi-
shot EPI describes the acquisition of k-space within a few TRs. Within this paper, all DWI 
images were taken using ss-EPI techniques. The standard method of covering k-space is a 
raster navigation, where lines of k-space are acquired in a back-and-forth scanning trajectory. 
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In this method, Gx (which is referred to as the frequency encoding gradient in EPI) is used to 
provide continuous back-and-forth movement between the edges of k-spaces. Gy (referred to 
as the phase encoding gradient in EPI) is blipped to switch between phase encoding lines. 
The EPI acquisition is typically centered on the echo, so that the center of k-space is acquired 
with maximum signal. A diagram of k-space navigation by this method and the EPI gradient 
waveform can be found in Figure 1-15. 
 
Figure 1-15: EPI k-space trajectory where the phase encoding direction is blipped, and 
the frequency encoding direction is continuous. 
EPI offers several advantages over conventional imaging, especially for DWI. The 
speed of imaging offered by EPI minimizes readout time and nearly eliminates motion 
artifacts. EPI also is advantageous for DWI because it enforces consistency in TE/TR across 
diffusion images, minimizing sources of contrast besides spin mobility. 
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1.4.4.1 Multi-slice Acquisition 
Multi-slice acquisition uses composite RF pulses to excite multiple slices 
simultaneously. A delay is introduced in between excitation of different slices to create a 
phase difference in excited signal of different slices. These signals can then be separated in 
post-processing of the acquired signal to create images of separate slices (32). Because 
multiple slices can be acquired simultaneously, the scan time of sequences can be greatly 
reduced. 
1.4.4.2 Parallel Imaging 
Parallel imaging is a technique which accelerates acquisition by taking advantage of 
redundancy in k-space. In this technique, k-space is symmetrically under-sampled in the 
phase encoding direction. This under-sampling results in a reduced field of view (FOV) in 
uncorrected images, which is accompanied by wrap-around aliasing artefacts. Parallel 
imaging uses sensitivity maps from receiver coils as a separate source of location information 
to resolve aliasing and geometric distortion, as well as restore FOV. This correction may be 
applied through different techniques in both image space and k-space. Notable methods of 
performing these corrections include SENSE (61) and GRAPPA (62). Parallel imaging 
typically provides acquisition accelerations on the order of 2-4x. 
1.4.4.3 2D Selective RF Excitation 
A more recently developed technique utilized in the experiments of this thesis is 2D 
selective RF excitation by the method of Saritas et al. (63). Several methods of 2D RF 
excitation have been described previously, but this particular technique is superior because of 
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its compatibility with adjacent slice multi-slice acquisition. In this technique, an echo-planar 
blipped RF is applied within “excitation k-space” to excite a 2D slab of tissue. Excitation k-
space is analogous to image space in the frequency encoding or slice selection direction and 
cyclic in the phase encoding or slab selection direction. The phase encoding direction of 
excitation k-space creates a phase separation of water and fat due to chemical shift as phase 
evolves during the excitation period. 
This technique is advantageous for several reasons. The primary reason is because it 
is able to reduce the number of phase encoding lines during excitation without compromising 
the resolution. Shortened EPI readout has the benefit of reduced image distortion and 
artefacts. This shortened phase encoding direction must be applied on a “short” dimension of 
the organ of interest. In the case of tubular organs, such as the spinal cord and esophagus, 
two short dimensions are available. Typically, the AP direction is chosen to be shortened 
because it is most impacted by breathing motion. The second advantage of this technique is 
that it produces an intrinsic water-fat separation during phase encoding of excitation k-space. 
Fat separation is important for implementation of DWI, and in DWI scans which do not 
incorporate 2D selective RF excitation, other methods must be utilized to remove fat 
contribution from signal. 
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1.5 Hypothesis 
Two-week changes in quantitative DWI parameters are predictive of the response to 
neoadjuvant chemoradiation in esophageal cancer. 
1.6 Specific Aims 
Specific Aim I: To determine how early changes in DWI parameters in patients of 
esophageal cancer treated with chemoradiation correlate with measures of clinical outcome.  
Specific Aim II: To evaluate reproducibility of ADC measurements between readers 
for both volumetric and slice contouring methods.  
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2 Materials and Methods 
2.1 Patient Selection and Outcome Measures 
Patients afflicted with esophageal cancer between stages IIa and IIIb were enrolled 
into this ongoing prospective study starting in 2014. These patients were given standard of 
care treatment in the form of nCRT followed by surgical resection. Histopathologic analysis 
of resected tissue provided measures of % viable cells. Based on this measure, patients were 
classified into TRG’s according to the four-tier grading system. Disease progression after 
surgery was also tracked through follow-up for the purpose of eventual analyses of survival. 
Patients who deviated from the study protocol were considered inevaluable, and 
additional patients were enrolled. This study was approved by the MDACC IRB and patient 
consent was obtained in all cases. 
2.2 MRI Scan Protocols 
MR exams for each patient were performed at three points along the course of nCRT: 
before nCRT at baseline (BL), two-weeks into nCRT at interim (IM), and after completion of 
nCRT at first follow-up (FU). All scans were performed on a single GE 3.0 T MR750W 
scanner using a 32-channel phased-array body coil. At the start of this study, two separate 
DWI protocols were included in MR exams: a standard ssEPI diffusion scan for fitting with a 
mono-exponential model, and an rFOV scan by FOCUS (2D RF excitation method on GE 
platform) for fitting with an IVIM model. For the IVIM scan FOCUS protocol, the AP 
direction was chosen as the reduced phase encoding dimension. This dimension was reduced 
by half, resulting in a rectangular FOV. Later, in January 2016, another ssEPI scan with 
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higher b-values was added to the study for diffusion kurtosis analyses. Henceforth, these 
scans will be referred to by the diffusion model they were designed for: MONO, IVIM and 
DKI, respectively. For MONO and DKI scans, acceleration by parallel imaging was utilized. 
The typical acquisition parameters for these three scans are shown in Table 2-1. 
Table 2-1. Typical scan parameters for DWI scans. 
Protocol # of 
Slices 
TE 
(ms) 
TR 
(ms) 
Thickness 
(mm) 
Matrix FOV 
(cm) 
Approx. Scan 
Time (m:s) 
MONO 50 69.7 5195 4.0 96 x 96 46 x 46 4:41 
IVIM 16 62.4 3000 4.0 96 x 96 24 x 12 5:38 
DKI 40 52.7 4500 4.5 96 x 96 42 x 42 6:21 
 
For each DWI scan, diffusion images were taken using a distinct selection of b-
values. For the MONO scan, b-values were selected based on the methodology of Padhani et 
al. (26). This methodology requires the selection of three b-values. First, a b0 image is 
acquired for reference to T2 images. Second, a mid-range b-value (between 200 and 500 
s/mm2) is selected, which will aid ADC fitting by measuring signal loss at a lower b-value. 
The exact value of this mid-range b-value is specific to the anatomic site being imaged, and 
must be high enough to avoid variation in perfusion effects on signal loss. In the esophagus, a 
b-value of 200 s/mm2 is sufficient for this purpose. Finally, a third high b-value must be 
included. This is to further characterize signal loss from diffusion in the mid b-value region 
where signal loss is dominated by diffusion. For the esophagus, a value of 800 s/mm2 was 
chosen. 
40 
 
For IVIM scans, several low and intermediate b-values were chosen to separately 
characterize diffusion and perfusion effects. For DKI, several intermediate and high b-values 
were chosen to separately characterize Gaussian diffusion and diffusion impacted by 
kurtosis. Higher b-value diffusion images were acquired with multiple excitations (NEX, 
number of excitations) and averaged. The benefit of NEX is increased SNR. SNR increased 
with the square root of the number of NEX taken. B-values and their respective NEX for 
each of the diffusion scans are presented in Table 2-2. 
Table 2-2. B-values and NEX for diffusion scans. 
Protocol b-values (s/mm2) [NEX] 
MONO 0 [2] , 200 [2], 800 [6] 
IVIM 0 [2], 30 [2], 60 [2], 100 [4], 600 [16] 
DKI 200 [2], 600 [4], 1000 [8], 1200 [12], 1600 [16] 
 
For each scan, diffusion sensitization gradients were applied in three directions for 
each non-zero b-value, and averaged to provide combined diffusion images. All diffusion 
scan were acquired with free-breathing of the patient. Neither co-registration nor geometric 
correction was applied to diffusion images. Although these corrections would provide benefit 
by minimizing distortions and misalignment between diffusion images due to motion, there is 
evidence that non-linear effects on signal level from these corrections leads to incorrect 
estimation of diffusion parameters. An experiment performed in-house using standard 
correction methods revealed a change of up to +/-5% in ADC values for MONO scans. 
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2.3 Diffusion Parameter Mapping 
Diffusion parameter map estimation was performed using an in-house software 
named ImageI, which was designed and developed in our own lab. This software was 
implemented in the Matlab application development environment (Mathworks, Natick, MA). 
ImageI offers a convenient environment and a variety of useful features for the work 
performed in this project. Its capabilities will be expounded in the relevant methods sections 
of this thesis. For fitting of parameter maps, ImageI uses slightly differing methods of non-
linear least mean square (LMS) curve fitting for each model. Calculating ADC is 
accomplished by finding the LMS solution for ADC on a voxel-by-voxel basis using all three 
b-values. In ImageI (Matlab), this is implemented using the pinv function, as shown in the 
pseudo-code of Equation 15. 
 
 
 
Equation 19: Pseudo-code for Mono-exponential ADC Estimation 
#Calculate signal ratios in log(S/S0) form 
Diff_image = diffusion_images(b0,b200,b800)./diffusion_images(b0_meas) 
Diff_image = log(Diff_image) 
 
#Solve inverse squares problem to estimated ADC 
pb = pinv(-200,-800); 
For All Voxels 
 ADC = pb*Diff_image(b200,b800) 
End 
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In the case of fitting the MONO diffusion images with a mono-exponential model, 
ImageI was validated against an industry standard available in the Functool application of the 
AW workstation by GE (Boston, MA). For the specific case of measuring ADC mean across 
volume contours of esophageal cancer, the GE and ImageI methods of producing ADC maps 
have been shown to be equivalent. Further details on this comparison can be found in the 
Appendix 5.1.  
A second method of ADC calculation described by Padhani et al. was compared with 
the ImageI and industry-validated methods (26). The Padhani et al method does not use b0 
images for ADC estimation and instead directly calculates ADC from the solution of b200 
and b800 signals. ADC estimation in ImageI was also another standard method of ADC 
calculated by b0 and b800 is also included. The results of this comparison are shown in the 
Appendix 5.6. A graph of the curve fitting of MONO signal levels for an individual voxel 
can be seen in Figure 2-1. 
 
Figure 2-1: Comparison of LMS fitted ADC plot with plotted measured signal values for 
a single voxel. 
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Industry standards for fitting IVIM and DKI models are not yet available from GE 
AW Functool. Because of this, the ImageI methods for estimating these parameter maps has 
not been validated against an industry standard. In the case of IVIM, a variety of parameter 
fitting methods have been described in literature (64). The method used by ImageI is well-
established (65). In this method, an initial guess for the true-diffusion coefficient, D, is 
calculated from a direct solution of signal levels from two diffusion images. From this initial 
ADC estimate, an estimation of S0 is then calculated. Then, the difference between the 
estimated S0 and measured S0 is divided by the measured S0 to create an initial guess for the 
perfusion fraction, f. These initial guesses were combined into the LMS algorithm for the 
estimation of IVIM parameter maps. During LMS estimation, S0 signal levels were allowed 
to iteratively change from the measured S0 signal. This flexibility allows for better fitting of 
lower b-value signals with the IVIM model. Pseudo-code for this non-linear LMS 
implementation is shown in Equation 20. A graph of the curve fitting of IVIM signal levels 
for an individual voxel can be seen in Figure 2-2. 
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Equation 20: Pseudo-code for IVIM Parameter Mapping 
 
 
Figure 2-2: Comparison of LMS fitted IVIM model with measured signal values for a 
single voxel. 
For DKI parameter fitting, initial estimates of ADC and S0 were also obtained using 
b200 and b600 images. These estimates were used in a non-linear LMS estimation 
#Calculate signal ratios in log(S/S0) form 
Diff_image = diffusion_images(b0,b30,b60,b100,b600)./diffusion_images(b0_meas) 
Diff_image = log(Diff_image) 
 
#Use LMS to solve for ADC 
For All Voxels 
parameter_holder=lsqcurvefit(@((1-f)exp(-b.*D)+(f)exp(-b.*D*)),initial_guess,Diff_image) 
End 
#Where parameter_holder is a 4D matrix containing 3D maps of perfusion fraction, pseudo-diffusion 
coefficient, true-diffusion coefficient, and final b0 estimation. 
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implementation similar to IVIM, as shown in Equation 21. A graph of the curve fitting of 
DKI signal levels for an individual voxel can be seen in Figure 2-3. 
 
 
 
 
#Calculate signal ratios in log(S/S0) form 
Diff_image = diffusion_images(b200,b600,b1000,b1200,b1600)./diffusion_images(b0_est) 
Diff_image = log(Diff_image) 
 
#Use LMS to solve for ADC 
For All Voxels 
parameter_holder=fminsearch(@(sum(Diff_image,exp(-b.*ADC+b2.*ADC2.*k)),initial_guess,Diff_image) 
End 
#Where parameter_holder is a 4D matrix containing 3D maps of ADC and k. 
Equation 21: Pseudo-code for DKI Parameter Mapping 
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Figure 2-3: Comparison of LMS fitted DKI model with measured signal values for a 
single voxel. A plot of the kurtosis model is seen in red, while a plot of the DKI-calculated 
ADC as a mono-exponential decay is seen in green. Deviation of the signal from mono-
exponential behavior can be seen at high b-values. 
Across all models, some numeric bounds were used to mask out non-physical values 
for diffusion parameters. For the diffusion parameters ADC, D*, D, and k, negative values 
were excluded. For the perfusion fraction f, negative values or values above 1.0 were 
excluded. No other exclusion of diffusion parameters was made based on their quantitative 
values. 
ImageI offers fast, automated import of DICOM files followed by automatic 
calculation of parameter maps. On a multi-core external server, estimation of parameter maps 
of scans with parameters matching those in Table 2-1 took approximately 2 minutes for 
MONO scans, 30-40 minutes for IVIM scans, and 1.5-2 hours for DKI scans. After 
estimation of parameter maps, ImageI creates a single database file (.dat) which contains 
diffusion images, parameter maps, patient information, and a reserved space for contour 
masks. 
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2.4 Contour Measurements of Diffusion Parameters 
To measure diffusion parameter values within each tumor, contours delineating the 
tumor from surrounding tissue were produced. Besides the technology used to make these 
contours, a few strategies to ensure consistency and accuracy of contours were developed. 
2.4.1 General Contour Strategies 
Across the contouring methods used in this paper, a few general strategies were used. 
First, all contours were performed on b200 images for MONO and DKI, and b100 for IVIM. 
This was chosen out of the possible options of contouring on any of the diffusion images or 
the ADC map. The decision to avoid contouring on b0 images was simple: although b0 
images have the highest signal, they do not contain diffusion contrast needed to delineate 
tumors. Higher b-value images and ADC maps were not chosen as contouring images 
because although they are highly tumor specific, heterogeneity within the tumor may lead to 
high variations in high b-value diffusion images and ADC maps. This heterogeneity could 
cause readers to contour only certain sections of the tumor with more hindered diffusion. For 
volume contouring, it is important to include all voxels of the tumor so as to completely 
capture the diffusion behavior throughout. Another simple and more practical reason was 
included in the decision to contour on lower b-value diffusion images: at later stages of 
treatment, diffusion becomes less hindered. This reduces signal in the higher b-value 
diffusion images, making contouring more difficult by manual and semi-automatic 
contouring methods. By using a lower b-value, greater ease of contouring on IM and FU 
scans was achieved. 
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A second contouring strategy was introduced for the purpose of delineating the 
superior and inferior (SI) extents of the tumor (proximal and distal by GI anatomy). For 
contouring on diffusion images, the poor resolution in the slice dimension (4-4.5 mm in these 
scans) makes location of the superior and inferior slices of the tumor difficult. This difficulty 
is most severe at the inferior extent in tumors at the GE junction, where T2 shine-through of 
cardium tissue is a large issue. To standardize contouring measurements in this dimension, a 
method was created for finding this superior and inferior extent of the tumor. In the case of 
using this method on MONO scans, the b200 map is first used to locate the tumor. Then, 
approximate superior and inferior boundaries based on b200 images are found. After this, the 
reader will switch to ADC maps on a nearby slice where tumor location is certain. The dark 
area of the ADC map corresponding to the area of the tumor is then located. This dark region 
of the ADC maps is traced through slices until it disappears. This disappearance is far more 
distinct than SI changes in the b200 diffusion images, and marks the SI boundaries of the 
tumor. These boundaries can then be propagated to b200 diffusion images for contouring. 
Visualization of this phenomena on MONO exams is shown in Figure 2-4. 
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Figure 2-4: This figure demonstrates the indistinct SI boundaries in the b200 images and 
the distinct SI boundaries in ADC maps. It can be seen that the b200 images demonstrate 
a noticeable, but indistinct lowering of signal as slices are they sequentially examined in 
the inferior direction towards the inferior boundary of the tumor (upper row, 
leftright). The ADC map (bottom row) demonstrates a distinct inferior boundary 
when examined in this manner, which can be noticed as a large rise in ADC values 
between the second and third image. Red arrows in the leftmost images mark areas of 
low ADC corresponding to tumor, and the red arrow in the third image marks where 
this area of low ADC is missing. 
A third contouring strategy was added to account for cases in which tumor signal 
dropout occurs on a single slice on the diffusion images of the b-value used for contouring. 
This “flashing” artefact may occur because of large motion or single slice failure of parallel 
imaging correction. Flashing artefacts are easy to notice by the readers. When encountered, 
the entire slice can be excluded to prevent skewing the estimation of the tumor ADC. Images 
of this artefact and others can be found in the Appendix 5.4. Other b-value images were not 
searched for flashing artefacts so as to minimize time needed for contouring. 
A fourth contouring strategy was developed to deal with misalignment of diffusion 
images due to motion and distortion. The method is simple: readers would slightly under-
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contour the edges of tumors. This prevents the inclusion of the incorrectly estimated ADC 
values present at tumor borders misaligned between diffusion images.  
The last notable contouring strategy used in this research was to exclude the lumen of 
the esophagus. ImageI has a salient feature to allow “holes” in the images to be excluded 
within contours. This exclusion allows further implementation of the under-contouring 
method around the interior edges of the tumor. Morphologic distention within the esophagus 
may also trap fluids within the lumen. Inclusion of voxels containing trapped liquid would 
not be representative of the tumor and would artificially raise ADC summary measures 
extracted from the contour. An example of lumen exclusion can be seen in the results section 
(Figure 3-2). 
2.4.2 Software Implementation 
Contour measurements were performed across MONO scans of all surgical patients 
using two distinct methods: volumetric contouring and slice contouring. Volumetric 
contouring is only available through research tools. In the current clinical setting of 
MDACC, only slice contouring is currently available through the PACS system.  
2.4.2.1 Volumetric Contouring 
Volumetric contouring was accomplished through the combined use of two software: 
ITK-SNAP (www.itksnap.org.) (66) and ImageI. Although ImageI is initially used for 
DICOM import and parameter map estimation, primary delineation of the tumor was 
performed in ITK-SNAP. 
ITK-SNAP is an open-source, semi-automatic contouring suite. It offers user-guided 
semi-automatic contouring by the level-set algorithm, among several other algorithms (66). 
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Contouring by the level-set algorithm is advantageous for diffusion images because the level-
set algorithm is robust to high signal variation (66). This is especially important for 
propagation of contour boundaries in the low-resolution slice direction of diffusion images. 
Within ITK-SNAP, DICOM files of the diffusion images used for contouring (EX: 
b200 for MONO) were imported. Contours were then produced using the Active Contour 
Segmentation option. For pre-segmentation, the Thresholding method was used, with a 
maximal selected upper threshold and a user-prescribed lower threshold. From here, several 
3D “bubbles” were placed as seeds from which the initial iteration of the contour would 
propagate. Bubbles were selectively placed to ensure propagation of contour throughout all 
sections of the tumor. After this, contour evolution was executed and then terminated when 
the tumor was encompassed. Usually, this resulted in a useable contour. A full guide with 
screenshots visually detailing the steps of this method is shown in the Appendix 5.2. Once a 
useable contour was derived using ITK-SNAP, a binary mask was exported in DICOM 
format and then imported into ImageI. 
Fine manual adjustments and finalizing of the contour were performed after the initial 
delineation by using the toolbox available within ImageI. It provides paintbrush and eraser 
tools, as well as polygon and freehand semi-automated contouring by the Snake algorithm. 
ImageI also allows for histogram slider exclusion of signal values across tumor volume or 
individual slices. With these tools, contours were finalized by erasing areas where the semi-
automatic contour had propagated into adjacent tissues and by smoothing the edges of the 
contours to fit the tumor boundaries. 
After contouring was completed, extraction of diffusion parameters was executed 
using ImageI. This included the following summary measures across volume extracts of 
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diffusion parameters: max, min, mean, standard deviation, median, histogram kurtosis, 
histogram skewness, 10th percentile, 25th percentile, 75th percentile, and 90th percentile. 
ImageI also extracted the length of contoured SI extent and contoured tumor volume. It 
should be noted that in this instance, histogram kurtosis examines the kurtosis of diffusion 
parameter levels across a histogram of voxels in the contour. This should not be confused 
with the kurtosis effect observed in high b-value diffusion imaging. 
A separate extraction of all diffusion parameter summary measures was made for the 
largest single slice within the contour. This was done with the intent of acting as a proxy for 
single slice contouring. Comparison of largest slice metrics with actual single slice 
contouring can be found in the Appendix 5.7.  
All extracted measures were combined and exported into an Excel file using a single 
button click within ImageI. A full workflow map of all steps between acquisition and 
extraction by volume contour can be found in Figure 2-5. 
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Figure 2-5: Workflow for measurement of diffusion parameters through volume 
contouring. 
It is important to note that contouring performed by the initial reader (the author of 
this thesis) was not performed using ITK-SNAP. The previously described contouring 
method was only used by the readers in the inter-reader study. Contouring by the initial 
reader (R1) was performed manually using the contouring toolbox within ImageI. Further 
details on the strategies of their implementation is presented in the Appendix 5.3. 
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2.4.2.2 Slice Contouring 
The implementation of slice contouring is more simplistic than that of volume 
contouring. First, ADC maps generated by GE Functool using diffusion images were 
exported to PACS. Then, using localizer mode within Phillips Intellispace, freehand contours 
were drawn onto the ADC map while tracing the b200 image. From here, ADC mean and 
standard deviation of the contour were recorded. This measurement was only performed on a 
single slice. Slice selection was left to each reader, whose only guidance in this selection was 
to select a slice which was at the midline of the tumor and judged to have the largest cross 
section. With this slice contouring method, readers were unable to exclude the esophageal 
lumen. 
Within Phillip Intellispace, freehand contours were saved as presentation states and 
then reviewed later to insure correct recording of ADC mean and standard deviation. A full 
workflow map for estimation and measurement of diffusion parameters by slice contouring 
can be found in Figure 2-6. 
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Figure 2-6: Workflow for measurement of diffusion parameters through slice contouring. 
2.5 Inter-Reader Study 
For the inter-reader study, four additional readers contoured MONO scans using both 
volumetric and slice contouring techniques. These readers included an experienced thoracic 
radiation oncologist, an experienced thoracic radiologist, and two radiation oncology 
residents. Before contouring, readers were given training across several datasets. They were 
then assigned randomized orders in which to contour all surgical MONO exams. They 
completed contours of these exams as volumetric contours using previously described 
volume contour methods and with slice contouring using the clinically available method. 
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Throughout contouring, all readers were blinded to the contours of other readers as well as 
the histopathological groupings of the patients.  
2.6 Statistical Analysis 
Statistical analysis was performed in Matlab, an open-source statistics software 
named R (GNU), and Prism by GraphPad Software (San Diego, California). P-values less 
than 0.05 were considered statistically significant. 
2.6.1 Correlation of Diffusion Parameter Summary Measures with 
Histopathology 
Diffusion parameters summary measures were compared for heterogeneity between 
tumor histologic groupings. Two major comparisons were made. The first compared 
diffusion parameter summary measures between TRG1, TRG2 and combined TRG3+ using 
one-way three-factor ANOVA or the Kruskal-Wallis (KW) test. A second method compared 
diffusion parameter summary measures between a binary grouping of patients as pCR 
(TRG1) and non-pCR (combined TRG2 and TRG3+) using a non-parametric t-test or Mann-
Whitney (MW) u-test. The second comparison between binary groupings was extended to 
receiver operator curve (ROC) analysis. Optimal cutoff for classifying patients into the 
binary grouping were calculated using Youdens’s index. To test for the possibility of 
building a multi-parametric model, Spearman’s rank was used to assess correlation between 
diffusion parameter summary measures. 
A third, less important comparison was also applied, where the binary definition was 
altered so that patients with <1% viable cell histopathology were compared with pCR 
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patients and a grouping of >=1% viable cells patients. This comparison is not relevant to a 
clinical endpoint. Instead, this comparison was performed to examine the sensitivity of 
quantitative diffusion parameters to differences between histopathologic groups which are 
seemingly close (0% viable cells vs <1% viable cells). Results of this comparison can be 
found in the Appendix 5.5. 
2.6.2 Inter-Reader Reproducibility Analysis 
Inter-reader reproducibility was evaluated through three methods. First, quantitative 
measures were compared for reproducibility between readers using Bland-Altman analysis. 
Bland-Altman analysis results in a metric known as the 95% Limits of Agreement (LOA), 
which shows the likely distance between measurements of a system by separate readers. 
Second, contouring measures of individual readers were examined for performance under ROC 
analysis using the binary patient grouping. Both of these methods were applied to results 
obtained through both volume and slice contouring. 
Finally, comparison of spatially contoured volumes was compared between readers 
using the Dice Similarity Coefficient (DSC). This was performed using Equation 22. 
Equation 22: 𝑫𝑺𝑪 =  
# 𝒐𝒇 𝑺𝒉𝒂𝒓𝒆𝒅 𝑽𝒐𝒙𝒆𝒍𝒔
(# 𝑽𝒐𝒙𝒆𝒍𝒔 𝒊𝒏 𝑪𝒐𝒏𝒕𝒐𝒖𝒓 𝑨)+(# 𝑽𝒐𝒙𝒆𝒍𝒔 𝒊𝒏 𝑪𝒐𝒏𝒕𝒐𝒖𝒓 𝑩)
 
Averages of DSC’s across patients and between all pairings of readers were found for 
BL, IM and FU separately. Average DSC for each individual reader across all pairings to other 
readers, all patients, and all time-points were also calculated. 
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3 Results 
3.1 Patient Enrollment 
In total, 59 patients have been enrolled in the study. Several patient enrolled in the 
study did not undergo surgery because their disease had already metastasized, they had poor 
cardiopulmonary health, or they refused surgery (n = 39).  These patients are not included in 
this analysis because currently elapsed follow-up time is inadequate for outcome analysis 
based on survival measures. The remaining 20 surgical patients are included within this 
analysis. According to the histopathological analyses of these twenty surgical patients, five 
exhibit pCR to nCRT (TRG1/pCR: n = 5), nine exhibit partial response to nCRT (TRG2: n = 
9) and six patients exhibit limited response to nCRT (TRG3: n = 6). A more complete 
presentation of patient characteristics can be found in Table 3-1. 
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Table 3-1. Patient and Pathology Characteristics 
Characteristic N (%) 
Gender 
Male 
Female 
 
20 (100.0) 
0 (0.0) 
Age (years) 62.1+/-8.0* 
Histological Tumor Type 
Adenocarcinoma 
Squamous cell carcinoma 
 
17 (85.0) 
3 (15.0) 
Histological Tumor grade 
Well Differentiated 
Moderately Differentiated 
Poorly Differentiated 
 
0 (0.0) 
9 (55.0) 
11 (45.0) 
Clinical Stage 
IIa 
IIb 
IIIa 
IIIb 
 
1 (5.0) 
5 (25.0) 
12 (60.0) 
2 (10.0) 
Tumor Location 
Proximal third 
Middle third 
Distal third 
Gastro-esophageal junction 
 
0 (0.0) 
1 (5.0) 
17 (85.0) 
2 (10.0) 
Histopathologic T-stage 
ypT0 
ypT1a 
ypT1b 
ypT2 
ypT3 
 
5 (25.0) 
2 (10.0) 
2 (10.0) 
3 (15.0) 
8 (40.0) 
Histopathologic N-stage 
ypN0 
ypN1 
ypN2 
ypN3 
 
14 (71.4) 
4 (20.0) 
2 (10.0) 
0 (0.0) 
Histopathologic Tumor Regression Grade 
TRG 1 
TRG 2 
TRG 3-5 
 
5 (25.0) 
9 (19.0) 
6 (30.0) 
*Patient age is listed as mean+/-std 
 It should be noted that Table 3-1 describes the patient characteristics of all patients 
who underwent surgery and had useful MONO exams at BL and IM. For IVIM, one patient 
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(TRG1) is excluded because of a failed baseline exam (n=19 for BL and IM). Four patients 
did not receive FU exams because of loss to follow-up (Remaining MONO at FU: n=16; 
TRG1 = 4, TRG2 = 6, TRG3 = 6). In addition to this, IVIM scans were mistakenly not 
acquired at FU for three additional patients (remaining IVIM at FU: n=13; TRG1 = 3, TRG2 
= 5, TRG3 = 5). 
3.2 Image Quality 
With the exception of a baseline IVIM exam with failed acquisition (n=1), all other 
acquired diffusion exams were of sufficient quality for quantitative volume measurements. 
Examples of images by exam type can be found in Figure 3-1, Figure 3-2, and Figure 3-3 for 
MONO, IVIM, and DKI, respectively. 
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Figure 3-1: Diffusion images (a, b) and ADC map (c) from MONO exam of a patient at 
BL. Contours made on b100 are overlain on the image in white. FDG-PET (d), T2-
weighted image (e), and CT (f) images of the approximate slice are included for 
comparison. 
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Figure 3-2: Diffusion images (a, b) and parameter maps (d-e) from IVIM exam of a 
patient at BL. Contours made on b100 are overlain on the image in red. A T2-weighted 
image (c) of the approximate slice is included for comparison. 
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Figure 3-3: Diffusion images (a-c) and parameter maps (d,e) from DKI exam of a patient 
at BL. Contours made on b200 are overlain on the image in white. A T2-weighted image 
(f) of the approximate slice is included for comparison. 
Several artefacts were seen in the images: “flashing” artefacts (parallel imaging 
failure or large motion on a single slice), slight misalignment due to motion, and T2 shine-
through artefacts. Flashing artefacts were excluded through avoidance of single slices during 
contouring, and occurred infrequently (around 1 to 2 flashing artefacts for every 5 scans). T2 
shine-through resulted in subjectivity in contouring the inferior edge of tumor at the 
gastroesophageal junction. Images and further details of these artefacts can be found in the 
Appendix 5.4. 
Two major errors in scan acquisition occurred while obtaining scans of surgical 
patients. The first was the failed baseline IVIM scan due to failed calibration. The second 
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major error was a calibration failure during the first five slices of a MONO scan. Because the 
tumor was not near the location of these slices, the scan was considered useable and included 
in this analysis. 
3.3 Correlation of DWI Parameters with Histopathology 
Unfortunately, DKI data cannot be reported upon presently because of insufficient 
patient accumulation (n = 25 patients, only 2 with surgery). The results of correlation of 
diffusion parameter summary measures of MONO (n=20) and IVIM (n=19) with 
histopathology are presented here for the volume contouring of the initial reader. 
3.3.1 Mono-exponential Model (ADC) 
Across ADC summary measures at all time-points and as relative changes between 
time-points, any differences between 3-factor TRG groupings detected with KW test were 
simply the extension of differences displayed with the binary grouping method (pCR vs non-
pCR). No difference was found between the ADC summary measures in TRG2 and TRG3+. 
Because of this, KW test results are not reported here in favor of the binary comparison by 
MW test. 
At baseline, four summary measures of ADC were found to be significantly different 
(p<0.05) by MW test between pCR and non-pCR. ADC mean and ADC median tied for the 
most significant, with MW p-values of 0.0261 and AUC’s of 0.840. Statistical analysis and 
values of these summary measures can be found in Table 3-2. 
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Table 3-2. Comparison of Baseline ADC Summary Measure Distributions between pCR 
and non-pCR using Mann-Whitney Test. 
ADC Summary Measure p-value TRG ADC in x10-3 mm2/s AUC  
ADC Mean 0.0261 
TRG1 
TRG2 
TRG3 
2.22 +/- 0.17 
2.68 +/- 0.38 
2.48 +/- 0.28 
0.840 
ADC Median 0.0261 
TRG1 
TRG2 
TRG3 
2.18 +/- 0.16 
2.66 +/- 0.41 
2.45 +/- 0.30 
0.840 
ADC 75th Percentile 0.0403 
TRG1 
TRG2 
TRG3 
2.57 +/- 0.21 
3.08 +/- 0.40 
2.86 +/- 0.33 
0.813 
ADC 25th Percentile  0.0493 
TRG1 
TRG2 
TRG3 
1.82 +/- 0.15 
2.27 +/- 0.40 
2.10 +/- 0.28 
0.800 
 
Baseline values of volume ADC mean were not significantly different between ESCC 
patients (n=2) and AEC patients (n = 18) using MW u-test (p>0.08). MW test did not 
demonstrate any difference in distribution of ADC summary measures between pCR and non-
pCR patients at IM or FU. 
Relative change in ADC (ΔADC) summary measure at IM produced excellent 
separation between binary grouping of patients as pCR and non-pCR. Several ADC summary 
measures resulting in AUC=1 by ROC analysis. The top five ΔADC summary measures by 
MW p-value are listed in Table 3-3. 
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Table 3-3. Comparison of Distributions of ΔADC Summary Measures between pCR 
and non-pCR using Mann-Whitney Test. 
Summary Measure p-value TRG Relative % Change (Mean +/- STD) AUC 
ADC Mean 0.001063 TRG1 
TRG2 
TRG3 
37.73 +/- 8.77 
9.17 +/- 9.43 
9.77 +/- 4.01 
1.000 
ADC 25th Percentile 0.001063 TRG1 
TRG2 
TRG3 
47.12 +/- 11.18 
9.55 +/- 10.51 
11.60 +/- 4.40 
1.000 
ADC 10th Percentile 0.001063 TRG1 
TRG2 
TRG3 
53.23 +/- 20.46 
8.60 +/- 15.26 
12.51 +/- 7.31 
1.000 
ADC Median 0.001443 TRG1 
TRG2 
TRG3 
39.63 +/- 9.20 
10.59 +/- 9.38 
10.74 +/- 3.65 
0.987 
ADC 75th Percentile 0.001944 TRG1 
TRG2 
TRG3 
35.73 +/- 12.11 
10.37 +/- 10.08 
8.07 +/- 4.98 
0.973 
 
Youden’s index was used to calculate an optimized cutoff for the top performing 
parameter, ΔADC mean. This value was found to be a 27.7% change in ADC mean. A dot plot 
comparing ΔADC mean between pCR and non-pCR can be found in Figure 3-4. 
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Figure 3-4: Comparison of distributions in ΔADC mean between pCR and non-pCR 
groupings. P-value by MW test is shown at top. The 27.7% cutoff between pCR and 
non-pCR is shown as a dotted line. 95% confidence intervals and means are displayed 
with crosshairs for each group. 
By Spearman’s rank, the top ΔADC summary measures at interim were found to be 
highly correlated. This result is depicted for the top 10 performing ΔADC summary measures 
in Figure 3-5. 
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Figure 3-5: Spearman’s correlation matrix of the top 10 performing summary measures 
of ΔADC. 
 No difference in distributions of ΔADC summary measures at FU was found between 
pCR and non-pCR. Change in contoured tumor volume between BL and IM or FU were not 
significantly different between binary response groups. 
3.3.2 IVIM Model 
As with MONO, any differences between 3-factor TRG groupings detected with KW 
test were simply the extension of differences present in the binary grouping method (pCR vs 
non-pCR). Because of this, only differences based on the binary grouping are presented in this 
section. 
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Many baseline summary measures of IVIM parameters were highly different between 
pCR and non-pCR groupings. The IVIM parameter summary measure with the highest MW 
p-value at BL was D min, with an AUC = 0.950 by ROC. The top 5 performers by MW test p-
value are shown in Table 3-4. 
 
Table 3-4. Comparison of Baseline IVIM Parameter Summary Measures 
between pCR and non-pCR using MW test. 
Summary Measure p-value TRG D/D* (x10-3 mm2/s) AUC  
D 
Min 
0.00693 
TRG1 
TRG2 
TRG3 
0.0613 +/- 0.1226 
0.5045 +/- 0.2207 
0.3534 +/- 0.2422 
0.950 
D* 
Mean  
0.00932 
TRG1 
TRG2 
TRG3 
12.05 +/- 2.87 
18.79 +/- 6.43 
18.44 +/- 2.80 
0.933 
D 
Mean 
0.0124 
TRG1 
TRG2 
TRG3 
1.04 +/- 0.53 
2.08 +/- 0.59 
1.74 +/- 0.40 
0.917 
D 
25th Percentile 
0.0124 
TRG1 
TRG2 
TRG3 
0.80 +/- 0.49 
1.70 +/- 0.53 
1.40 +/- 0.35 
0.917 
D 
Median 
0.0124 
TRG1 
TRG2 
TRG3 
1.02 +/- 0.53 
2.03 +/- 0.58 
1.70 +/- 0.38 
0.916 
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When IVIM parameters summary measures were compared between pCR and non-
pCR as relative changes at IM, 10 were found to be significantly different between groups. Of 
these, only two were not summary measures of the true-diffusion coefficient (D): pseudo-
diffusion D* 90th percentile and perfusion fraction f 90th percentile. A list of these summary 
measures, their MW p-values, and their AUC’s can be found in Table 3-5. 
Table 3-5. Comparison of Distributions of ΔIVIM Summary Measures at IM between 
pCR and non-pCR using Mann-Whitney Test. 
Summary Measure p-value TRG Relative % Change (Mean +/- STD) AUC 
D  
90th Percentile 
0.00270 TRG1 
TRG2 
TRG3 
40.35 +/- 17.89 
9.75 +/- 12.75 
4.31 +/- 5.90 
1.000 
D  
mean 
0.00270 TRG1 
TRG2 
TRG3 
43.48 +/- 16.69 
9.50 +/- 11.76 
6.99 +/- 10.18 
1.000 
D  
Max 
0.00270 TRG1 
TRG2 
TRG3 
33.75 +/- 13.91 
1.29+/- 7.93 
0.51 +/- 9.45 
1.000 
D  
25th Percentile 
0.00270 TRG1 
TRG2 
TRG3 
47.58 +/- 21.80 
8.77 +/- 10.88 
8.17 +/- 14.61 
1.000 
D  
75th Percentile 
0.00373 TRG1 
TRG2 
42.70 +/- 17.78 
10.38 +/- 13.05 
0.983 
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TRG3 6.43 +/- 8.55 
D  
Median 
0.00373 TRG1 
TRG2 
TRG3 
44.81 +/- 16.01 
10.26 +/- 12.23 
8.44 +/- 11.23 
0.983 
D*  
Min 
0.00767 TRG1 
TRG2 
TRG3 
662.26 +/- 650.29 
62.98 +/- 212.26 
0.73 +/- 55.03 
0.933 
D  
Standard Deviation 
0.01242 TRG1 
TRG2 
TRG3 
39.81 +/- 25.64 
9.90 +/- 13.65 
0.24 +/- 7.63 
0.917 
f  
90th Percentile 
0.02781 TRG1 
TRG2 
TRG3 
31.68 +/- 18.63 
10.63 +/- 11.15 
8.29 +/- 12.31 
0.867 
D  
10th Percentile 
0.02781 TRG1 
TRG2 
TRG3 
53.57 +/- 43.60 
7.25 +/- 12.27 
9.28 +/- 15.24 
0.867 
 
Youden’s index was used to calculate an optimized cutoff for the top performing 
parameter, ΔD 90th percentile. This optimized cutoff was also found to be a 27.7% change in 
D 90th percentile. A dot plot comparing ΔD 90th percentile between pCR and non-pCR can be 
found in Figure 3-6. 
72 
 
 
Figure 3-6: Comparison of distributions in ΔD 90th Percentile between pCR and non-pCR 
groupings. P-value by MW test is shown at top. The 27.7% cutoff between pCR and non-
pCR is shown as a dotted line. 95% confidence intervals and means are displayed with 
crosshairs for each group. 
By Spearman’s rank, the top 10 ΔIVIM summary measures at interim were found to be 
highly correlated. This result is depicted in Figure 3-7. 
 
73 
 
 
Figure 3-7: Spearman’s correlation matrix of the top 10 performing summary measures 
of IVIM diffusion parameters as relative change at IM. 
For IVIM, several significant differences in distributions of ΔD and ΔD* summary 
measures as relative changes at FU were found between pCR and non-pCR. These results are 
not clinically useful because they do not predict response at an early time-point. All of these 
measures are listed in Table 3-6. 
Table 3-6. Comparison of Distributions of ΔIVIM Summary Measures at FU 
between pCR and non-pCR using Mann-Whitney Test. 
Summary Measure p-value TRG Relative % Change (Mean +/- STD) 
D*  
Standard Deviation 
0.0102 TRG1 
TRG2 
TRG3 
66.42 +/-  35.51 
11.06 +/-  17.42 
-61.92 +/-  52.36 
D  
min 
0.0158 TRG1 
TRG2 
TRG3 
7.53E10 +/-  1.30E11 
30.28 +/-  100.21 
-57.00 +/-  58.90 
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D  
Max 
0.0240 TRG1 
TRG2 
TRG3 
52.42 +/-  46.42 
-9.15 +/-  18.89 
-56.60 +/-  60.41 
D*  
90th Percentile 
0.0240 TRG1 
TRG2 
TRG3 
111.49 +/-  60.33 
17.13 +/-  34.78 
-63.18 +/-  50.82 
D*  
Mean 
0.0356 TRG1 
TRG2 
TRG3 
110.36 +/-  106.42 
22.80 +/-  45.18 
-63.29 +/-  50.56 
D* 
75th Percentile 
0.0356 TRG1 
TRG2 
TRG3 
163.58 +/-  193.84 
33.39 +/-  63.21 
-62.21 +/-  52.78 
 
 It is interesting to note that D summary measures were better classifiers of the binary 
grouping as relative changes at IM, while D* summary measures were better classifiers of 
the binary grouping as relative changes at FU. Change in contoured tumor volume between 
BL and IM or FU were not significantly different between binary response groups. 
 Because D from IVIM and ADC from MONO are both estimations of the diffusion 
coefficient, it was thought that a comparison of these estimations may be interesting. This 
comparison can be found in the Appendix 5.8. 
3.4 Inter-Reader Study 
Results of the inter-reader study as 95% LOA and AUC analysis can be found for top 
5 performing ADC summary measures by volume contouring and all slice contouring ADC 
measures in Table 3-7. Bland-Altman plots are presented for the top performing summary 
measures of ADC as decided by maximum AUCmin (ΔADC 25th Percentile and mean) in Figure 
3-8. 
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Table 3-7: Inter-Reader Reproducibility for MONO ΔADC Summary Measures by 
Bland-Altman and ROC Analyses. 
ΔADC 
Summary Measure 
95% LOA 
(per sd) 
AUC 
R1 R2 R3 R4 R5 
Volume 10th Percentile 0.940 1.000 1.000 0.987 1.000 0.960 
Volume 25th Percentile 0.944 1.000 1.000 0.987 1.000 1.000 
Volume Mean 1.001 1.000 1.000 0.973 0.973 1.000 
Volume 75th Percentile 1.010 0.973 1.000 0.947 0.880 0.933 
Volume Median 1.021 0.987 1.000 0.933 0.960 1.000 
       Slice ADC Mean 1.517 0.893 0.800 0.880 0.773 0.880 
Slice ADC STD DEV 1.738 0.507 0.533 0.613 0.600 0.600 
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Figure 3-8: Bland-Altman plots comparing inter-reader variability for ADC 25th 
percentile (a) and ADC mean (b) from MONO scans. 
Comparison of contoured volumes across all patients and all possible reader pairings 
produced average DSC’s of 0.73, 0.66, and 0.56 for BL, IM, and FU, respectively. The 
maximum average DSC for all possible pairings of a single reader across all patients and 
time-points was 0.69. The minimum average DSC for all possible pairings of a single reader 
across all patients and time-points was 0.61. 
4 Discussion 
4.1 Response Prediction by DWI 
The results of this study have shown diffusion parameters to be highly useful for 
classification of surgical patients as pCR or non-pCR. Although the measured diffusion 
parameters at baseline were significantly different between groups, the relative changes at 
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interim in these diffusion parameters provided substantially better classifications of the 
different patient TRG groups. Summary measures of ADC by MONO scans and D by IVIM 
scans were able to perfectly classify patients by the binary response grouping. The minimum 
value of D by IVIM scan at BL was an excellent classifier of the binary response grouping, but 
is based on the measurement in a single voxel, making it unstable. 
Results for the MONO exam closely parallel those from a previous study by Van 
Rossum et al (29). Van Rossum’s study was organized nearly identically to this one in terms 
of size, scan protocol, and patient histology. They found that an optimized cutoff of 29% 
relative change in ΔADC median at interim best separated their pCR and non-pCR patients. 
This is strikingly similar to the 27.7% result found in this study. Agreement between these two 
papers was achieved in spite of geographically separated patient populations (North America 
vs Western Europe) and different magnet strengths/manufacturers (GE 3.0 T vs Phillips 1.5 
T). This study serves as a good validation of their results. 
Thus far, only a single paper has been published on the use of IVIM in esophageal 
cancer (67). This paper is not comparable to the data in this thesis because it does not concern 
response to therapy and was performed with a patient population dominated by ESCC. 
4.2 Reproducibility of Contour Measurements between Readers 
Inter-reader reproducibility by Bland-Altman and ROC analysis showed excellent 
reproducibility for measurements of several ΔADC parameter summary measures. The top 
performing summary measure of ΔADC was the 25th percentile because it had the highest 
minimum AUC between all readers (0.987). Slice contouring showed poor reproducibility 
with a high 95% limit of agreement (1.517) and low AUC across all readers. It is evident that 
slice contour is insufficient for measuring ADC for the prediction of response. 
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It is interesting that the lower percentile measures of ΔADC (10th and 25th percentile), 
show better LOA and AUC in comparison to other percentile measures (Table 3-7). This may 
have two plausible explanations.  The first is that lower values of ADC correspond to higher 
signal on the diffusion images. Because high signal is the primary marker of tumor voxels in 
diffusion images, it is more likely that areas of low ADC will be contoured by different 
readers. A second explanation is the direct interpretation: change in diffusion behavior in the 
most hindered voxels of the tumor is more representative of response to nCRT. This has been 
shown previously for prediction of response to CRT in other anatomic sites (68-70). It is 
likely that the reason for this result is a combination of these two factors. 
DSC analysis for spatial agreement of contours may be interpreted using the 
following ranges: values are considered by where they fall in the following ranges: 0.00–0.20 
poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good and 0.81–1.00 excellent agreement 
(71). At BL and IM, average DSC fell into the “good” range, meaning that reproducibility of 
spatial volume contours was good between readers. Average DSC for individual readers 
across all patients and time-points was always above 0.61, meaning that all readers within 
this study were able to perform contouring with spatial location that was in good agreement 
with their peers. Results similar to this have been obtained by another group for contouring 
on diffusion images of rectal cancer (72, 73). 
Because of the excellent performance of MONO scans with respect to classifying 
pCR and reproducibility of contour measurements, we have not examined the inter-reader 
reproducibility for IVIM scans. 
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4.3 Limitations 
A major limitation of this work is the small dataset of surgical patients (n = 20). It is 
unlikely that the perfect separation of pCR and non-pCR patients will continue in a larger 
dataset. This is evident in the small difference between the 27.7% cutoff and the highest % 
ΔADCmean from the non-pCR group (27.04%), as well as the difference between the 27.7% 
cutoff and the lowest ΔADCmean from the pCR group (28.39%). 
Another limitation is the use of histopathological response as a proxy for survival 
measures. Although histopathologic measures are highly predictive of survival, direct 
knowledge of survival is far more powerful for the purpose of retrospective classification. 
A third limitation is the location of the tumors in this study. Most of the tumors were 
located in the distal third of the esophagus (n = 17, 85%). Only a few of the tumors were 
located in the GE junction (n=2, 10%).  The patient population of this study is not 
representative of the general population, where incidence in the GE junction is more likely. 
Accurate contouring is more difficult at the GE junction due to the T2 shine-through artefact 
of the stomach. Because of this, diffusion parameter measurement in the general population 
may be less reliable, which may impact the predictive value of DWI for response to nCRT. 
4.4 Future Work 
First, these results must be validated in a larger dataset. This will be accomplished 
through the continued accrual of surgical patients, combination of these results with those 
reported by Van Rossum et al., and through eventual KM analysis of non-surgical patients. 
Surgical patients should also undergo KM analysis, as histopathology measures do not hold 
the same value as survival measures. 
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After this biomarker has been validated in a larger dataset, it must be tested 
prospectively in a randomized Phase I clinical trial. In the experimental group of this trial, a 
patient whose intra-tumoral volume ADC increases sufficiently to predict pCR from 
chemoradiation alone will be withheld from surgery and placed under a wait-and-see 
approach. Other patients in this experimental group whose change in volume ADC predicts 
partial response will be sent for surgery (if able). In the control group, all patients will 
undergo surgery if able, regardless of change in volume ADC. By comparing survival of 
these two groups, it can be fully established if using DWI to predict response and avoid 
surgery in pCR patients holds a clinical benefit. 
For routine clinical use, a consistent and fast method of volume contouring of 
diffusion images must be made available. The volume methods in this paper are fairly time 
consuming, requiring approximately 5 minutes of time for an experienced reader to complete 
a contour. In clinical workflow, this is much longer than a radiologist would typically spend 
reading an image dataset. Thus, it would be advantageous if a robust, fully-automatic method 
was clinically available for contouring. Recently, a paper has been published which uses 
convolutional neural networks to contour stroke lesions on DWI of the brain (74). This and 
other methods of automatic contouring may be investigated for their capabilities towards 
contouring of diffusion images with reduced reader intervention and oversight. 
It is possible that the lack of success of FDG-PET as a predictor of response is caused 
by the non-specific uptake of FDG at IM such as from radiation induced inflammation. Non-
specific uptake makes delineation of the tumor on FDG-PET/CT images difficult, and 
changes the values of summary measures such as standardized uptake value (SUV). It is 
possible that combined DWI with FDG-PET would provide better localization for tumor-
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specific measurement of FDG-PET summary measures at interim. Co-registration of these 
images would be improved if they could be acquired in a conserved frame of reference 
within a PET/MR system. If FDG-PET measures were also found to be useful for prediction 
of response, both FDG-PET summary measures and ADC summary measures could be 
measured using a single set of contours acquired in an efficient, single machine setting. This 
would be time-saving, and may improve delineation of the tumor for both modalities in 
comparison to contemporaneous and separate acquisitions.  
Once enough DKI patients have been accumulated, DKI will be investigated for 
potential value in prediction of treatment response in esophageal cancer. The kurtosis 
parameter has been shown as a useful biomarker of cancer in several anatomic sites (75-77). 
It may hold useful information distinct from ADC that can be used towards predicting the 
response of esophageal cancer to nCRT. 
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5 Appendix 
5.1 Validation of ADC Map Calculation by Comparison to GE Functool 
For validation of ADC calculation by ImageI, ADC maps were generated using GE 
Functool within a GE AW workstation and imported into ImageI. ADC extraction was 
performed using each map on volume contours of five esophageal scans. These scans 
including separate patients, variability in tumor size, and at least one scan from each time-
point (BL, IM, and FU). Extracted volume ADC mean were compared between the two ADC 
mapping systems using an unpaired, two-sided Student’s t-test. Results of this comparison 
are shown below in Table 5-1. Student’s t-test did not reveal any significant difference in 
extracted volume ADC mean between the two methods (all p>0.46). 
Table 5-1. Comparison between extracted volume ADC mean from ADC maps 
generated by ImageI and GE Functool 
Scan # 
Volume 
(cm3) 
ImageI Mean ADC 
(x10-3 mm2/s) 
GE Mean ADC 
(x10-3 mm2/s) % Difference Student’s p-value 
Scan 1 19.05 1.667 +/- 0.305 1.667 +/- 0.305 -0.01% 0.99 
Scan 2 5.49 1.792 +/- 0.358 1.795 +/- 0.353 -0.17% 0.90 
Scan 3 25.61 2.086 +/- 0.414 2.086 +/- 0.414 0.00% 1.00 
Scan 4 10.29 2.074 +/- 0.506 2.079 +/- 0.613 -0.25% 0.83 
Scan 5 43.90 2.038 +/- 0.422 2.031 +/- 0.399 0.31% 0.46 
5.2 ITK-SNAP Settings and Guide 
This section is intended to act as a demonstration of our contouring technique in ITK-
SNAP. After diffusion images are imported into ITK-SNAP for contouring, the image must be 
prepared for semi-automated contouring through a series of pre-segmentation steps. In this 
example, the ITK-SNAP technique is applied to b200 images from a MONO scan.  First, the 
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reader should adjust the contrast by selecting Tools>Image Contrast>Contrast Adjustment. 
This should be adjusted to the reader’s preferences. Then, the reader must select the Active 
Contour Segmentation button, which is located on the upper left of the screen.  
This will bring up a screen where the reader is asked to shrink the volume of the image 
set to a small box which barely encompasses the tumor. This is done by dragged dashed red 
lines to the edges of the tumor. The reader must be careful to include the entirety of all the 
tumors dimensions by searching the axial, sagittal, and coronal views of the display. An 
example of this volume minimization can be seen in Figure 5-1. 
 
Figure 5-1: Minimization of volume for semi-automated contouring. The new smaller 
volume is outlined in red lines. The display includes axial (Upper Left), sagittal (Upper 
Right) and coronal (Bottom Right) views. 
84 
 
 Once the contouring volume has been shrunk, the user must select the Segment 3D 
button in the left toolbar. The displayed images will change to include only the minimized 
volume. The user must click on one of the small blue and white images displayed next to each 
of the anatomic views. This will change all of the displays into blue and white “speed images”, 
where a prediction of the semi-automatic contouring is displayed. White pixels represent pixels 
which are predicted to be in the contour and blue pixels represent pixels which are predicted 
to be excluded from the contour. For the protocol used in this paper, the Thresholding method 
should be selected in the pull-down tab on the right toolbar. The user should then select the 
More… button on the right toolbar to bring up a window showing application of threshold 
limits to an image intensity histogram. The user should adjust the upper threshold to its 
maximum limit. The lower threshold should be adjusted so that the predicted speed images 
include the entirety of the tumor while minimizing predicted contouring of outside tissue. After 
this step is complete, advancement to the next step can be accomplished by clicking the Next 
button on the right toolbar. An example of this completed step can be seen in Figure 5-2. 
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Figure 5-2: Final adjustments of thresholding for speed images of a minimized scan 
volume. The display includes axial (Upper Left), sagittal (Upper Right) and coronal 
(Bottom Right) views. 
The last pre-contouring step is the placement of bubbles seeds, from which the contour 
will propagate. For efficiency, a minimum number of bubble seeds should be placed. The 
bubble size should be increased to maximize their dimension while still containing most of 
their volume within the tumor boundaries. Multiple bubbles should be placed if the sections of 
the tumor are disconnected, especially in the low resolution slice dimension. To place a bubble, 
the reticle should first be placed in the middle of the tumor with a mouse click. Then the Add 
Bubble at Cursor button on the right toolbar should be clicked. The radius of the placed bubble 
can then be adjusted using the slider on the right toolbar. Incorrectly placed bubbles should be 
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deleted by selecting them in the list on the right toolbar and clicking the Delete Active Bubble 
button. Once bubble seeds have been placed, the Next button on the right toolbar should be 
clicked for advancement of the contouring step. An example of good bubble placement can be 
seen in Figure 5-3. 
 
Figure 5-3: An example of good bubble seed placement within the tumor volume. 
Next, the active contour must be activated. This can be done by clicking the “play 
button” on the right toolbar. Once the contour has propagated to the preferences of the reader, 
the “pause button” (which takes the place of the play button while active contours are being 
iteratively updated) should be clicked to stop the contour. If the contour is acceptable, it can 
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then be save and exported as binary masks in DICOM format. Screenshots of before and after 
active contouring can be seen in Figure 5-4 and Figure 5-5. 
 
Figure 5-4: Screenshot of active contouring step before active contouring is activated. 
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Figure 5-5: Screenshot of completed contour after iterative update of contour boundaries 
during active contouring has been stopped with appropriate timing. 
If the contour fails to propagate throughout the entire tumor during the execution step, 
Active Contour Segmentation may be repeated with additional bubbles or a lower signal 
threshold. If the contour propagates too far, but still encompasses the entire tumor, the contour 
can instead be corrected later.  
ITK-SNAP is an open-source software offering free downloads and tutorials. It is 
applicable to a wide range of biological imaging modalities. Excellent documentation, guides, 
and more can be found at <www.itksnap.org>. 
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5.3 Alternative Manual ImageI Contouring Method 
This technique is fairly simple to implement, but requires significant manual input. 
Despite this, good manual contours can be achieved with this method in under 5 minutes per 
scan. This is comparable to the semi-automated method for BL scans. For IM and FU 
 scans where diffusion is less restricted and signal is lower on diffusion images, this method 
may be faster than the semi-automated method. It can be accomplished in a series of three 
steps. 
 First, the reader must completely contour the tumor on all slices. This contour should 
be done roughly, the only goal being to completely encompass the tumor without including a 
significant amount of adjacent structures (cardium, aorta, etc). In ImageI, this is done with the 
paintbrush tool. An example of this rough outlining on a single slice can be found in Figure 
5-6. 
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Figure 5-6: Rough outlining of tumor using several sweeps of the paintbrush tool. This 
should take on the order of a few seconds for each slice. 
In the second step of this method, the rough contour will be drawn into the tumor edges 
by excluding lower signal values. This can be done across using the volume histogram slider 
in ImageI. Changes in the edges of the tumor should be tracked on a representative slice of the 
tumor. The readers should slowly raise the minimum included signal value bar until the edges 
of the tumor (including lumen) are contoured well. If the lumen is visible on any slices of the 
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scan, one of these slices should be chosen for observation during histogram signal exclusion. 
An example of this signal exclusion technique is shown for a single slice in Figure 5-7. 
 
Figure 5-7: Example of edge contouring and lumen exclusion through raising minimum 
included signal level using the volume histogram tool in ImageI. A red arrow shows the 
movement of the slider, which was manually dragged by the user. 
After the second step is applied, the contour should be nearly perfect. To complete the 
contour, the reader must examine every slice and manually extend or contract edges of the 
contour. The reader should also fill in any missing holes within the tumor contour that do not 
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correspond to lumen. An example of this effort is shown in Figure 5-8, where the edges of the 
lumen were expanded and the edges of the tumor were drawn in on the posterior side. 
 
Figure 5-8: Final completion of the contour by manual adjustment of edges with eraser 
tool. The red arrows show points where the contour from Figure 5-7 was adjusted. 
For further information about ImageI, please contact Dr. Jingfei Ma at the following 
email address: jma@mdanderson.org. 
93 
 
5.4 Diffusion Image Artefacts 
5.4.1 Flashing Artefacts / Single Slice Signal Drop Out 
 
Figure 5-9: Massive shift of tumor signal on a single slice due to motion, causing a 
“flashing” effect when slices are scrolled through quickly. This is caused large scale 
motion or by parallel imaging correction failure, which leads to wrap-around artefacts 
in the phase direction (middle image). 
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5.4.2 T2 Shine-through 
 
Figure 5-10: This is an example of T2 shine-through in the b200 image (a) and ADC map 
(b) of a MONO scan. In this scan, the cancerous area of the esophagus is labeled with a 
red arrow and healthy stomach is labeled with a blue arrow. Although the stomach is not 
cancerous and is not experiencing abnormal restriction of diffusion, its T2 is relatively 
long, causing it to be bright on the diffusion image. The ADC map accounts for T2 shine-
through, which is why the enhanced stomach on the diffusion image does not match with 
an area of low ADC (darker) on the ADC map. 
 
5.5 Comparison of Diffusion Parameter Measurements between Alternate 
Groupings of <1% Viable Cell Patients 
Comparison between ΔADC mean at interim from MONO scans is shown in Figure 
5-11. It is seen that patients with <1% viable cell pathology have distinct diffusion behavior 
from that of 0% viable cells. 
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Figure 5-11: Comparison of ΔADC mean at interim between an alternate set of viable 
cell groupings. The 27.7% cutoff between pCR and non-pCR is shown as a dotted line.  
5.6 Padhani et al. ADC Method Comparison 
In this section of the appendix, two methods of calculating mono-exponential ADC are 
compared to the non-linear LMS (b0, b200, and b800) used in this paper: direct solution by 
Padhani et al method (b200 and b800), and classic single b-value solution method (b0 and 
b800). These comparisons are made for mean volume ADC, both as individual measurements 
and relative change at IM. On average, mean volume ADC by Padhani et al. method was 42% 
lower than the estimate by LMS used in this thesis. This is an intuitive finding, as exclusion of 
b0 images would avoid perfusion effects at low b-value from propagating into the model. 
Adding b0 images forces the curve fitting to account for loss in signal due to perfusion, 
increasing ADC to account it. On average, mean volume ADC by the classic single b-value 
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method (b0, b800) was 5.2% lower than the estimation method of this paper. This is driven by 
the same mechanism, where inclusion of b200 images in this paper’s estimation method forces 
ADC to account for fast drop in signal at b200 due to perfusion effects in lower b-value ranges. 
Plots depicting correlation of the alternate methods with the method of this paper by linear 
regression can be found in Figure 5-12. 
 
Figure 5-12: Correlation of LMS Curve Fitting Method Mean ADC across all MONO 
Scans with Mean ADC by Alternate Methods of ADC Estimation. R2 values from linear 
regression are shown at the top. 
Differences in estimated mean volume ADC between any two methods were not 
different for any scan time-point (BL vs IM vs FU: KW test p-value >0.3 for either comparison) 
and was also not different between pCR and non-pCR groupings (MW p-value >0.12 for both 
comparisons). This implies that the differences were systematic. For separation of pCR and 
non-pCR groupings, AUC=1 was maintained for only the curve fitting and 0,800 methods. The 
method by Padhani et al. decreased AUC to 0.893. It is possible that a larger patient dataset 
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may favor one method of ADC estimation over the others for the purpose of predicting 
response in esophageal cancer. For this study, there is no sufficient evidence indicating 
favorability of one estimation technique over another. 
5.7 Comparison of Largest Slice and Single Slice Contour Measurements 
If isolating the largest slice from a volume contour was a good approximation of 
measurements by single slice contouring, mean ADC extracted from largest slice should 
correlate well with mean ADC from single slice contouring. This was compared individually 
for each of the readers in the inter-reader study. This correlation can be seen in Figure 5-13. 
Measurements of ADC mean by single slice contouring did not correlate well with 
measurement of ADC mean by largest slice according to linear regression This analysis is 
highly simplified for purpose of comparing measurement techniques (Bland-Altman analysis 
would be the proper method), but is enough to show that these techniques do not obtain 
comparable measurements in this application (across all readers: max R2 = 0.6162, min R2 = 
0.2887) 
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Figure 5-13: Correlation of ADC mean measurements by Largest Slice (y-axis) and Single 
Slice (x-axis) methods. Graphs are titled with their respective readers, and R2 values are 
shown at the top of the graphs. 
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5.8 Correlation of IVIM D and MONO ADC  
Because both ADC from MONO scans and D from IVIM scans are parameters to 
estimate the true diffusion coefficient, these parameters were compared. D from IVIM was 
compared with LMS MONO ADC and Padhani et al. MONO ADC. Volume mean D by 
IVIM was, on average, 41.5% lower than volume mean ADC by MONO with LMS fitting 
and 21.1% lower than volume mean ADC by MONO with the Padhani et al. method. A 
correlation of diffusion coefficient estimations is shown below in Figure 5-14. 
 
Figure 5-14: Correlation of Volume Mean D by IVIM with Volume ADC Mean by 
MONO through two different estimation methods. “LMS” corresponds to the MONO 
ADC method used in this paper, while “200 800” corresponds with the method put forth 
by Padhani et al. R2 values from linear regression are shown at the top. 
MONO ADC by the Padhani et al. method correlates better with D by IVIM. Neither 
of the ADC by MONO estimation methods were highly correlated with D by IVIM.  
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